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INTRODUCTION 
Remarkable advances have been made in trace mineral research, 
especially in the last decade (1). A number of elements, including zinc, 
have been found to be essential to man (2). Knowledge of interrelation­
ships between the actions of several nutrients in the body is growing. 
Zinc and copper, for example, compete for uptake in the intestinal lumen. 
This is due to similarity of their atomic orbitals. Selenium and 
mercury interrelate through direct chemical reaction. Phosphate 
(HPO^^), arsenate (AsO^^) and vanadate (VO^^) compete in the same way 
because of similarity of molecular orbitals (3). For totally different 
reasons, some nutrients exert very similar biological effects. The 
antioxidant effects of selenium and vitamin E are examples (4). Skin 
pathology produced by deficiency of essential fatty acids or zinc is 
another. There is also a whole range of very similar clinical 
symptoms which both protein-energy malnutrition (PEM) and zinc 
deficiencies share (5). 
The need to identify the exact roles of dietary zinc and protein 
in PEM has become increasingly necessary. Clinical findings are showing 
the presence of zinc deficiency in many cases of PEM (6, 7, 8). Thus, 
there is the possibility that the PEM syndrome may be an overlapping 
of the defxcxency symptoms of both protexn and z%nc* 
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REVIEW OF LITERATURE 
Brief History of Zinc 
Zinc was first recognized by Raulin in 1869 to be essential for 
Aspergillus niger. Somer and Lipman, in 1926, determined that it is 
essential for higher plants. Later, it was found to be essential 
for many experimental animals, including the rat (9). Its deficiency 
in man was first suspected in 1961 and established in 1963 (10) . Prasad 
and Oberleas (1) emphasizes the great importance of zinc by pointing 
out that its metabolic roles are so numerous "that biochemistry may 
have to be rewritten around this one element." 
Brief History of Protein-Energy Malnutrition 
The term "protein-calorie malnutrition" (PCM) was first introduced 
by Jelliffe (11) in 1959 to cover not only marasmus and kwashiorkor 
but also their mild subclinical stages. Some prefer the synonym 
"protein-energy malnutrition" (PEM) to "protein-calorie malnutrition." 
The preference is meant to emphasize that insufficient dietary energy 
leads to the metabolic energy deficiency of the syndrome and that the 
calorie is only the most customary measure of this energy. 
The newer term - "energy-protein malnutrition" (EPM) is coming into 
greater use (12) . This is to emphasize the unconfirmed suspicion 
that marasmus is the more predominant form of protein-energy malnutri­
tion rather than kwashiorkor. While an overall lack of food energy 
causes marasmus, kwashiorkor appears to be caused by a deficiency of 
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dietary protein. A definition of the three basic forms of PEM -
marasmus, kwashiorkor, marasmic-kwashiorkor - has been discussed by 
Waterlow (13). Edema and severe dermatosis are the distinguishing 
features of kwashiorkor. Extreme weight loss or growth failure 
typifies marasmus. 
Malnutrition has been known for centuries in many parts of the 
world. Commonly, it was in the form of marasmus in North America and 
Europe. Marasmus occurred elsewhere, too (14). Detailed study of PEM 
began in the 1920s. It, however, took the appointment of the first 
female medical officer (Cecily Williams) to Gold Coast (now Ghana) to 
give a detailed description of the disease in 1932 (12, 14). The disease 
she described was the kwashiorkor form of PEM. "Kwashiorkor" was the name 
of the edemic form of PEM in Gold Coast. For a time, some suspected it 
was "infantile pellagra" resulting from niacin deficiency. Later, Trowell 
(cited by Darby, 15) noticed unusually low plasma albumin levels asso­
ciated with it. Helen McKay suggested an association with dietary amino 
acid or protein deficiency. 
Cecily Williams admits not being the first to have described 
kwashiorkor. Her work opened the door, however, to serious work on PEM. 
In 1906, Czeny and Keller (Germany) called the syndrome 
"Mehlnachschwaden." In 1908, Correa (Mexico) called it "Celebrilla." 
In 1924, Phillip and Proctor (Kenya) called it "Oedema and Ascariasis." 
In 1926, Normet and Kerandel (Indochina) called it "Bouffisure d'Annan." 
In 1927, Frontali (Italy) called it "Starchy Food Dystrophy." 
4 
Numerically, PEM is adjudged the major cause of illness in the 
world today (16). Efforts in the last twenty years have helped to 
abruptly reduce mortalities from PEM. Unfortunately, mortality rates 
began increasing again in the 1970s, possibly because of rising food 
shortages and costs. 
Zinc and Protein in Diets 
Studies (17) show that not all dietary zinc may be available for 
absorption. It is less available in plant products than animal products. 
In plant products, it may be bound by fiber, phytate, calcium, starch 
or wheat proteins. Calcium does not inhibit zinc absorption in man but 
does in other animals (6). Contrary to popular thought, it is fiber 
and not phytate that binds more zinc (1). Fiber may be beneficial to 
health (18), but excesses, by causing mineral losses, can be detrimental 
to health. The optimum dietary level and type for health needs to be 
determined. 
Zinc availability is improved by dietary cysteine, histidine, 
ethylenediaminetetraacetate (19) and high dietary proteins (20). This 
might imply the likely involvement of dietary amino acids in the 
mechanism of zinc absorption. Protein deprivation can, on the other hand, 
cause negative zinc balance (21). This might explain the incidence of 
zinc deficiency in cases of PEM in Egypt, South Africa, and India (6, 7, 
8). Oberleas and Prasad (22) have suggested zinc-supplementation of high-
protein vegetable mixtures formulated to treat kwashiorkor. 
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Zinc intake should come from a balanced diet with adequate animal 
proteins. Meat, liver, eggs and seafood (especially oysters) are good 
sources of available zinc. Next follow milk and whole-grain products -
whole wheat, rye bread, oatmeal, whole com. Zinc content of most 
municipal water is negligible (23). Some of the best sources of animal 
protein (meat, liver, eggs, seafood and milk) are the best sources of 
available zinc. 
A zinc intake of 15 mg/day is recommended for adults, with an 
extra 5 mg/day in pregnancy and 25 mg/day total for lactation (23). For 
preadolescent children, a dietary allowance of 10 mg/day is recommended. 
Newborns have a negative zinc balance and declining tissue stores. There 
is uncertainty about the safety of interfering with this negative balance 
in newborns. An allowance of 3 mg/day for the first 6 months of life is 
recommended for them (23). 
Estimates of protein needs of man come under occasional review by 
international groups of experts (24). Daily recommended intakes are 
0.8 gm/kg body weight for adults and 2.4 gm/kg for infants dropping to 1.4 
gm/kg by one year of age. Increased intakes are recommended for preg­
nancy and higher intakes for pregnant teenage girls for their own growth 
as well as the baby's. These recommendations are valid only when 
energy needs are met. Insufficient energy intake will cause degradation 
of some of the recommended protein intake for energy (24). There is 
information about the percentage of each essential amino acid that a 
good quality protein should have and also the percentages required by 
various age groups (23). 
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Biological Significance of Zinc 
In 1956, "Present Knowledge in Nutrition" cited less than 5 known 
zinc-metalloenzymes. Today, about 80 zinc metalloenzymes are known 
(25). Some occur in plants, rats, yeasts, bacteria, man and other 
life forms. There are also nonenzyme proteins that bind zinc in the 
body. Metallothionein, transferrin and nucleoproteins bind about 2% of 
plasma zinc. Cysteine and histidine bind about 2%. Alpha^-macroglobulins 
firmly bind about 30%. Plasma albumin loosely binds about 66%. 
Some well-known zinc-metalloenzymes are carbonic anhydrase, aldo­
lase, lactic dehydrogenase, malic dehydrogenase, and alcohol dehydrogenase 
(e.g., retinol dehydrogenase). Others are glutamate dehydrogenase, 
pancreatic carboxypeptidases A and B, NADH diaphorase, alkaline phos­
phatases, thymidine kinase, RNA polymerase, DNA polymerase and 
pyridoxal phosphokinase (26). These enzymes do not respond to zinc-
deficiency to the same extent in all tissues. The tissues in which 
they are most affected in deficiency are seruir., bone, pancreas, and 
intestinal mucosa <27)- Within any one of these tissues, the different 
enzymes also show different sensitivities to zinc status. Some lose 
activity quickly while others do so only in severe zinc deficiency. There 
are differences in the zinc-ligand affinities of the various metallo­
enzymes that account for cuis. Those (e.g., alkaline phosphatase) that 
bind zinc loosely, quickly lose it during deficiency. Others like the 
dehydrogenases bind it tightly and lose activity only in severe de­
ficiency. Those enzymes with low zinc affinity tend to have high 
turnover of the enzyme protein in the tissues and vice versa. 
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Serum alkaline phosphatase loses about 48% of its activity in 
rats after four days on a zinc-deficient diet. Within 3 days of zinc 
supplementation, the activity returns to normal. This reduction in 
activity occurs before loss of appetite, reduction in growth or ap­
pearance of skin lesions. This enzyme and carboxypeptidase A are the 
ones that first respond to zinc-deficiency in man (28). Pancreatic 
carboxypeptidases A and B are important in protein digestion. The 
level of A is consistently depressed in zinc deficiency. Its activity 
in animals can fall 24% after 2 days on zinc-deficient diet, but this 
does not seem to affect protein digestion or digestibility significantly 
(29) .  
Carbonic anhydrase activity is most detectable in the blood, stomach 
and intestines. Blood activity falls in zinc deficiency. After about 30 
days however, the activity may be found the same as for the controls. 
This is caused by increased erythrocyte count in the deficient rats. 
Erythrocytes are rich in carbonic anhydrase. It is best then to express 
this enzyme's activity/unit of erythrocytes. A reduction in its activity 
can then be shown at any stage of zinc deficiency. It is suggested in 
these studies that enzyme activities should be expressed per gram of 
protein (1). 
No significant changes have been seen in most of the dehydrogenases 
in zinc-deficiency. Some studies seem to suggest a slight increase in 
activity in some of them. The exception is retinol dehydrogenase. Al­
together, alkaline phosphatase and carboxypeptidase A, which lose activity 
before any clinical symptoms appear, are suspected to be involved in 
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starting clinical symptoms of zinc-deficiency. The mechanism is not 
clear. 
Some Roles of Zinc and Protein 
Both zinc and protein deficiencies can separately impair vision. 
They seem to involve a common mechanism. Both deficiencies suppress 
protein synthesis. Retinol-binding protein concentration is decreased 
in the liver because of low protein synthesis. Vitamin A accumulates 
in liver for lack of retinol-binding protein (RBP) to mobilize it. The 
failure to move Vitamin A from liver reduces supplies of it to the 
eyes and can cause xerophthalmia (30a). Xerophthalmia literally means 
"dry eye." Secretions of the goblet cells of the conjunctiva dry up, 
leading to discontinuity of the fluid films usually present over the 
surface of the conjunctiva and cornea. This drying may be caused by 
various clinical conditions. Vitamin A deficiency is the commonest 
cause (30u, 3Gc). When, zinc fails tc reach rctinol dehydrogenase in 
zinc deficiency it causes degeneration of the cones and rods. Only 
severe zinc deficiency is reported to have this effect. The result is 
night blindness (31a, 31b). Retinol dehydrogenase is needed to change 
retinol to retinaldehyde for the cones and rods. Levels of serum zinc 
correlate with levels of serum retinol-binding protein and total serum 
protein. However, data on the correlation between plasma Vitamin A and 
zinc is conflicting (30c). Plasma Vitamin A is usually reduced in 
zinc-deficient animals. It is also reduced in animals on restricted 
food intake even when dietary Vitamin A and zinc are adequate. This 
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suggests the possibility that on a zinc-deficient diet, the lowered plasma 
Vitamin A may be due to the decreased food intake that accompanies zinc-
deficiency rather than to zinc-deficiency per se. More research is needed 
to clarify this. Like alkaline phosphatase, it is suspected that a deter­
mination of serum retinol-binding protein may be a good indication of zinc-
deficiency (32). Research is needed to decide which of the two indices may 
be more sensitive. 
The most crucial biological function of zinc seems linked with DNA 
and RNA syntheses and cell division (33). These involve the activities 
of thymidine kinase, RNA polymerase and DNA polymerase. Ribonuclease is 
—4 
also affected. At plasma zinc concentrations below 10 M, ribonuclease is 
activated and breaks down RNA. It has been shown in malnourished boys in Iran 
(34) that there is poor growth if dietary protein is adequate and zinc is 
deficient. 
In zinc deficiency, DNA synthesis decreases as a result of inability 
to incorporate thymidine into DNA (35). In one study, progressive fall of 
thymidine Incorporation into SKA of liver, kidney and spleen occurred within 
five days on zinc-deficient diet. Thymidine kinase is required for incor­
poration of thymidine into DNA (33). 
In PEM, there are not enough dietary amino acids for protein bio­
synthesis. In zinc deficiency, if amino acids are available, they 
can still not be used for protein biosynthesis. This explains the great 
similarity of symptoms produced by two deficiencies. 
Zinc affects protein utilization. Protein digestibility is not 
altered significantly despite the fall in carboxypeptidase A activity 
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(29). Net protein utilization (NPU), however, decreases in zinc 
deficiency. Urinary excretion of N and S also increase because of 
increased degradation of the sulfur amino acids (cysteine and methionine). 
This leads to an overall reduction of the tissue proteins of zinc-
deficient rats (36, 37). An abnormal pattern of plasma proteins also 
results (38). In zinc-deficiency, methionine and cysteine cannot be 
incorporated into body proteins (39). They are degraded and lost via 
urine, mainly as taurine (40). Cysteine is involved in forming a 
collagen precursor. Collagen is involved in wound-healing. Keratin, 
an albuminoid protein of skin is also rich in cysteine (or cystine). 
About four times as much cysteine goes to the skin and hair of control 
rats as in zinc-deficient rats. This disorder of sulfur-amino acid 
metabolism seems to contribute to the development of skin lesions 
and hair disorders in zinc deficiency. It also may explain the role of 
zinc in wound-healing (41). 
Zinc is involved also with some hormones. Crystalline insulin 
contains 0.5% zinc. Insulin contains two polypeptide chains and a 
total of 51 amino acids in the two (42). Zinc deficiency does not 
affect its activity significantly (1). There is, however, a decreased 
activity of insulin in PEM - this being a specific effect of protein 
deficiency (16. 43). Plasma insulin levels decrease in PEM. 
Glucose tolerance is impaired also. The severe loss of potassium 
which accompanies PEM is considered responsible for the lowered 
plasma insulin concentration and activity. Potassium is important 
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in the control of insulin secretion from the beta-cells of the 
pancreas (16). 
Growth hormone cannot induce growth in zinc deficiency. There 
may be adequate dietary protein and high growth hormone concentrations, 
but no growth occurs if zinc is deficient. Human growth hormone 
contains 240 amino acid residues (44). Its plasma concentration 
increases in PEM. It cannot stimulate growth but does stimulate 
lipolysis in PEM. Its concentration is inversely related to the 
concentration of plasma albumin in PEM (16). 
Cortisol levels also increase in PEM because of stress from 
infections as well as the overall decrease in catabolism. 
Zinc deficiency causes hypogonadism in male animals. This is not 
due to insufficient sex hormones. Though serum lutenizing hormone 
(LH) concentrations fall slightly, pituitary concentrations are 
unchanged. The serum fall is due to reduction in food intake rather 
than to zinc deficiency (45). Testes of male rats atrophy in zinc 
deficiency (1). Zinc is needed for spermatogenesis in males. The 
effect on females depends on degree of severity, timing and duration 
of deficiency. The estrous cycle may be severely disrupted in the 
female. There may be no mating. If pregnancy occurs, fetal malforma­
tion (i.e., teratogenesis) may occur (46). Teratogenicity from zinc 
deficiency has not been documented in humans. 
Unlike in zinc deficiency, in PEM, sex hormone lutenizing 
hormone and testosterone) concentrations are low. Low sex hormone 
makes sexual maturation impossible (47). This, together with the 
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disruption of spermatogenesis during zinc deficiency and an overlapping 
of the two disorders will cause double suppression of sexual 
maturation in young males. 
Aldosterone is a mineralocorticoid hormone produced under 
control of the renin-angiotensin hormone system. It is produced 
+ + by the adrenal cortex and promotes Na absorption and K excretion 
in the kidneys, sweat glands, salivary glands, intestinal mucosa, 
urinary bladder, etc. It thus helps regulate water and electrolyte 
balance (48). Its elevated level in plasma in kwashiorkor probably 
contributes to the high water and Na"*" retention and, perhaps, edema 
of kwashiorkor (49) . 
Zinc plays an important role in the immune system (36, 50). 
Zinc deficiency causes reduced thymus and spleen weights. Peripheral 
lymphocyte counts and serum gamma-globulins are also lowered, causing 
reduction in synthesis of immunoglobulins or antibodies. Zinc 
deficiency thus causes a suppression of immune response. 
On the other hand, prostaglandin synthesis increases in zinc 
deficiency (51, 52). There is increased lipolysis. There also may 
be an increase in microsomal phospholipids, leading to an increase in 
levels of unsaturated fatty acids. Increased polyunsaturated fatty 
acids furnish substrate for lipid peroxidation as well as for 
prostaglandin synthesis. 
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Zinc Absorption and Its Mechanism 
Intestinal zinc absorption decreases with age both in man and the 
rat. Most absorption occurs in the small intestine — especially mid-
jejunum. Only minimal amounts are absorbed in the cecum, stomach, and 
colon (20). Only about 5-15% of the total dietary zinc is absorbed in man 
(53). Figures vary. Absorbed zinc is taken up by different tissues at 
different rates. Peak uptake in the rat occurs in the liver and pancreas. 
3-4 hours after ingestion of food. Zinc accumulation is slow in the 
blood cells, femur and muscles. The majority of the zinc ultimately 
is deposited in the muscle, bone, and skin of the rat. In PEN, plasma 
but not erythrocyte zinc is lowered (8). Individual cells with 
the highest zinc concentrations are those of liver, pancreas, kidney, 
heart, pituitary, adrenals, prostate gland and leucocytes. Erythro­
cytes contain 6-8 times more than plasma. Erythrocytes are rich in 
carbonic anhydrase, a zinc-metalloenzyme. 
Hansen and Lehnian (54) have reported a drastic fall in liver zinc 
in PEM. Zinc is known to have a protective effect on the liver, partly 
because of its inhibition of lipid peroxidation in cell membranes. 
In stress, body zinc is redistributed. In some inflammations, zinc 
moves from the plasma and accumulates in the liver. In PEM, zinc moves 
into the sdetaa fluid. With normal zinc intake, healthy animals have 
low urinary zinc excretion and high fecal zinc excretion. Fecal zinc 
is a combination of unabsorbed dietary zinc and endogenous zinc secreted 
from the vascular spaces into the intestines. In man, as much as 18% of 
intravenous ^^zinc may be excreted into the intestine (53). Aging 
13 
may increase this endogenous zinc loss. The small intestine is the main 
site of return of endogenous zinc into the gastrointestinal tract (20). 
Some endogenous zinc is also lost via pancreatic and biliary excre­
tions, e.g., as part of pancreatic carboxypeptidases. Endogenous zinc 
loss may be twice as much as urinary zinc excretion. Loss via urine 
can be enhanced by excess dietary histidine. This urinary zinc loss 
leads to lowered blood zinc. Small amounts of zinc are also lost 
from nails and falling hair. 
The mechanism of zinc absorption is still unclear but various 
hypotheses have been advanced. There is scientific evidence for 
and against each of them. It is accepted generally that the mechanism 
involves active transport from the lumen of the gastrointestinal tract 
(GIT). A ligand is believed to be secreted into the lumen, which binds 
dietary zinc for absorption. After extensive study, Evans et al. (55) 
proposed the following mechanism: "The pancreas secretes a ligand into 
the duodenum where zinc complexes with it. Thus complexed with the 
ligand, the zinc gets transported through the microvilli into the epi­
thelial cells where the metal is transferred to binding sites on the 
basolateral plasma membrane. Metal-free albumin interacts with the 
plasma membrane and removes zinc from the receptor sites." 
Hurley et al. (56a, 56b) reported finding such a zinc-binding ligand 
in human and rat milk and its absence from cow's milk. It is a low 
molecular-weight ligand that workers have conflictingly identified as 
prostaglandin (57), picolinic acid (58), citrate (59) and a metallo-
thionein degradation product (60). Evans and Johnson, early among 
those thinking it was prostaglandin, later identified it as picolinic 
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acid. Lonnerdal et al. (59) think it is citrate. They found the zinc-
binding function associated with citrate rather than with picolinic 
acid in chromatographic studies. The problem with the citrate hypothesis 
is that while the zinc-binding ligand (ZBL) shows high activity in 
human milk and little activity in cow's milk, citrate does the opposite. 
Also, there is known to be ZBL activity in rat milk while citrate has 
no activity there. In acrodermatitis enteropatica (AE) an infant 
disease caused by zinc malabsorption, the ligand is thought to be pro­
duced in insufficient amounts. Evans et al. observed correction of 
this disorder when human milk rather than cow's milk was given to 
children with the disease. Human milk is rich in picolinic acid. 
Casey et al. (61) demonstrated, however, that when zinc tolerance 
tests are used, no picolinic acid uptake by AE patients is seen. They 
finally concluded that ZBL is a degradation product of metallothionein. 
Some metallothionein is located in intestinal mucosa cells. It has 
been demonstrated that zinc absorption is directly proportional to 
intestinal metallothionein levels. 
Recent work by Hurley and Lonnerdal (56b) suggests strongly that the ZBL 
may be citrate. 
PEM Symptoms Vs. Zinc-Deficiency Symptoms 
A great number of the symptoms of PEM also occur during zinc 
deficiency (7) (see Table 1). 
Some symptoms unique to PEM are irritability, fatty liver and 
occasional diarrhea. Those unique to zinc deficiency are geophagia, 
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Table 1. Identical symptoms of PEM and zinc deficiency 
PEM Zinc-deficiency 
Growth failure 
Lethargy 
Loss of appetite 
Skin defects 
Enlarged liver 
Hair loss and abnormalities 
Hyperammonemia 
Impaired mental function 
Vitamin A accumulation in liver 
Growth failure 
Lethargy 
Loss of appetite 
Skin defects 
Enlarged liver 
Hair loss and abnormalities 
Hyperammonemia 
Learning disabilities in rats 
Vitamin A accumulation in liver 
loss of taste acuity (i.e., hypogeusia) and hypogonadism. 
In an experimental production of edema, Kohman (62) explained 
that rats with edema consistently show reduced testicle size. It is 
possible that this is an effect of underlying zinc deficiency. 
Conclusion 
Treatment of clinical PEN involves dietary therapy. In a study of 
kwashiorkor in Egypt, Sandstead et al. (6) found that at clinical recovery, 
the patients' plasma zinc was still below normal (90 + 10 l^g/dl) (1). 
In similar studies by others (8), plasma zinc rose to normal after 
three days of diet therapy. What were the differences between the 
two treatments? The latter study did not last long enough to 
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see the full effect of the early restoration of plasma zinc level on 
recovery. The authors point out, however, that zinc content of their 
therapeutic diet provided only (3.4 mg zinc/day) a fraction of the 
recommended dietary allowance 10.0 mg/day for children (23). It is 
known that inadequate dietary zinc during therapy, can slow down the 
rate of recovery (63). It can particularly slow down "catch-up growth" 
during recovery (34). Some clinicians consider a child recovered and 
ready for discharge when he reaches a normal weight-for-height. The 
normal weight-for-height is the 50 percentile weight for a given height 
and age, according to the Boston Standards (13). 
I hoped through this study to be able to examine some questions 
more closely. What will happen to PEN development if the full require­
ment of zinc is being supplied? What contributions do dietary protein 
and zinc make to the PEM syndrome? To what extent does low dietary 
protein affect dietary zinc absorption? 
With PEN being numerically the major cause of illness in the world 
(16), the effects of all factors that affect it need to be examined. 
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MATERIALS AND METHODS 
Four experiments were carried out: three depletion experiments 
followed by a depletion-repletion study. 
Care of Animals 
In the first three experiments, rats were ordered from Biolab^. 
Rats for the 4th experiment were obtained from Quality Laboratory 
2 
Animals because of some problems Biolab was having at the time. 
The rats were received at the age of 3 weeks — just after weaning. 
All were males of the Wistar strain. They usually had a weight distribu­
tion range of about 40-60 g. They were kept individually in stainless 
steel wire mesh cages. Since the cages were in galvanized steel racks, 
plexiglass sheets were inserted between their tops and the horizontal 
partitions of the racks. That way, the rats could not gnaw at the rack 
and obtain zinc. 
All glassware, drinking bottles, food jars, mortars and pestles 
used were acid-washed with 2N HCl. Nitric acid was avoided for washing 
because of its ability to bind zinc firmly to glass (64). Because of 
this, blank solutions became an absolute necessity when nitric acid had 
to be used in a perchloric acid wet-ashing procedure (65). Food and 
dëionizad water were provided ad libitum. 
In addition to assigning a specific number to each cage, each 
^Biolab Corp., Box 8586, 5228 Centerville Road, St. Paul, Minnesota 
55110. 
2 Quality Laboratory Animals, Box 4220, Madison, Wisconsin 53711. 
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treatment was identified with a specific color code. Ventilation in the 
animal room provided 5-6 changes of air per hour to remove moisture, 
bacteria and dust. Temperature was maintained at 77-78°? and relative 
humidity at 45-55%. A cycle of "lights-off" from noon to midnight and 
"light£-cn" from midnight until noon was maintained. That way, most 
handling could be kept within the morning hours with lights-on. The noise 
level in the room was kept at minimum. Cages and accessories were 
changed once a week. Until drinking bottles and food jars were re­
placed with fresh ones, care was taken to avoid interchanging them. The 
environment was kept clean. 
Compositions of diets used in these experiments are shown in 
Table 3. Zinc levels of various batches of diet (prior to zinc-
supplementation) ranged from 0.40-0.95 ppm. Dietary zinc analyses 
included a perchloric acid digestion (65) and analysis with an atomic 
absorption spectrophotometer. 
All the experiments, except Experiment II followed a 2 x 2 factorial 
design. This meant four different dietary treatments ~ two low protein 
diets (LPLZ and LPHZ) and two high protein diets (HPLZ and HPHZ). 
Table 2, Design of dietary treatments 
Treatment Zinc (mg/kg) Protein (%) Abbreviation 
1 6 0.4 LPLZ 
2 30 0.4 LPHZ 
3 6 20 HPLZ 
4 30 20 HPHZ 
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Table 3. Composition of diets 
Ingredients 
Low protein basal diet^ 
% weight 
High protein basal diet^ 
% weight 
Egg albumin^ 0.4 20.0 
Corn starch^ 84.1 64.5 
Corn oil^ 9.0 9.0 
Water-soluble vitamin 
premix® 1.0 1.0 
Fat-soluble vitamins^ 
(in oil) 1.0 1.0 
Zinc-free mineral mix^ 4.5 4.5 
Total 100.0 100.0 
^To each of these, zinc is later added as ZnS04*7H20 at two different 
levels (30 ppm and 6 ppm) to make a zinc-adequate and a moderately zinc-
deficient diet. 
^Spray-dried. United States Biochemicals. 
'^Teklad Test Diets. Zinc-free. Division of ARS/Sprague Dawley. 
"iCN Pharmaceuticals, Life Sciences Division, Cleveland, Ohio. 
^Based on National Academy of Sciences nutrient requirement of the 
rat with additional allowances. Used analytical grade reagents only. 
Amount on 100 kg diet: riboflavin, 1 gm; thiamine«HC1, 0.5 gm; 
pyridoxine*HCl, 2.8 gm;. Calcium pantothenate, 7.2 gm; vitamin Bi2> 2.0 mg; 
choline chloride, 90 gm; folic acid, 0.5 gm; biotin, 1.0 gm; inositol, 
40 gm; retinol acetate, 72 mg; vitamin D2 (ergocalciferol), 150,000 lU; 
dL-a-tocopherol acetate, 14,000 mg. 
^Based on National Academy of Sciences nutrient requirements of the 
rat with additional allowances. Used analytical reagents only. Amount 
in 100 kg diet: calcium, 600 gm; chlorine, 60 gm; sodium, 252 gm; 
phosphorus, 500 gm; selenium, 10 mg; potassium, 897 gm; iodine, 100 mg; 
manganese, 7 gm; magnesium, 60 gm; iron, 5 gm; chromium, 500 mg; copper, 
1.5 gm. 
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The low protein and high protein diets are isocaloric. Each diet pro­
vides about 4317 calories/kg. 
For normal weight gain in human infants, 5.5% of total dietary 
energy must come from protein (66). For rapid "catch-up" growth during 
recovery from PEM, the protein:energy ratio must be about 0.1, i.e., 
protein must provide about ten percent (10%) of the total dietary energy 
(63, 66). In our experimental diets, protein provided 0.4% and 19% 
of the total dietary energy of our low protein and high protein diets, 
respectively. These meant P:E ratios of 0.004 and 0.19, respectively. 
Experiment I 
The objectives of this experiment were to find out how long it would 
take to induce kwashiorkor using the low protein diets to check effects 
of different dietary zinc concentrations on PEM development, and to 
follow the entire course of the disease until death. 
A 2 X 2 factorial design was used. Forty-three male weanling 
rats were randomly assigned to the four diets so that there were at lease 
9 rats/treatment. The experiment lasted 84 days (i=e., 12 vseks). 
Blood samples were collected on the 2nd, 9th and 84th days of the 
study from the tail tip. These went into heparinized containers for 
plasma preparation. Plasma was stored at -20°C. 
Weekly weights and food intakes were recorded. Observations on 
general behavior and appearance of edema were made. 
Urine samples were collected on days 35 to 38 of the study — for 
72 hours exactly. Anodized aluminum gauze replaced galvanized gauze 
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in the funnels for urine collection. Hydrochloric acid (2 ml IN HCl/ 
bottle) served as a preservative. Total volumes were measured and 
samples frozen and later freeze-dried. 
Body lengths of all rats involved in the urine collection were 
measured from the nose tip to the base of the tail. 
Any deaths among the rats on the various treatments were re­
corded. Blood collection at the end of the study was by heart-puncture. 
Gastrocnemius muscles, liver, spleen and both kidneys were removed, 
blotted and weighed just after death. They were wrapped in aluminum 
foil, immediately frozen in liquid nitrogen and stored at -20OC in 
polyethylene bags. 
Experiment II 
The purpose of this study was to find the effects of dietary zinc 
on survival rate during PEM. 
Only thz lev protein diets — LPLZ (6 ppm zinc) and LFHZ (30 pom 
zinc) were used in this study. Thirty male weanling wis tar rats were 
assigned to each treatment. Experimental feeding lasted 12 weeks. 
Observations on general behavior, skin, eye and edema changes were re­
corded. Liver and Gastrocnemius muscles were removed from dead rats. They 
were immediately blotted, weighed, frozen in liquid nitrogen and stored 
at -20OC in polyethylene bags. 
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Experiment III 
The purpose of this study was to check the reproducibility of some 
of the findings of Experiment I and to also look at new parameters. 
A 2 X  2 factorial design involving all four treatments was used. 
Forty-eight weanling male wistar rats were randomly assigned such that 
there were 12 rats/treatment. Body weight data were collected at the 
beginning and end of the study. 
For necropsy, rats were anesthetized with ether and blood was 
collected by cardiac puncture and placed in heparinized containers. 
Plasma was stored at -20®C. Gastrocnemius muscles, mid-brain and 
liver were collected, blotted and weighed. They were wrapped with 
aluminum foil, quickly frozen in liquid nitrogen and stored at -20°C 
in polyethylene bags. 
Experiment IV 
This experiment was undertaken to find the effects of zinc status 
during depletion on subsequent rate of recovery from PEM. The depletion 
part also offered an opportunity to recheck some of the findings of 
Experiments I and III. 
Depletion-Repletion 
The 2x2 factorial design was used again. A total of 96 rats were 
randomly assigned with 24 rats/treatment and weighed weekly throughout 
the study. 
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After four weeks, all rats were fed the HPKZ (control) diet, 
except the 24 rats that were to be killed that day. 
The depleted animals were anesthetized with ether before sample 
collection. Blood was collected by heart puncture and put into 
heparinized containers for plasma preparation. 
The liver was perfused in each animal as part of this study. 
This was to check whether perfusion would significantly change the 
pattern of results obtained in Experiments I and III for the liver -
especially iron concentration. To perfuse, water was injected via the 
hepatic portal vein into the liver and out via the vena cava. This 
resulted in a pale brownish liver, cleared of blood. Livers were then 
removed, blotted, wrapped in aluminum foil and immediately frozen in 
liquid nitrogen. They were weighed and stored at -20°C. 
The remaining rats on control diet were weighed each week. 
Batches of 24 rats (6/treatment) were sacrificed at the end of the 
5th, 6th and 7th weeks of study. Blood and liver samples were collected 
and processed as before for storage at -20*C. 
Analytical Procedures 
Dietary zinc 
Digestion of diet was done with a perchloric acid-nitric acid 
procedure (67). Samples were made up to volume with deionized water 
and analyzed with an atomic absorption spectrophotometer. 
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Plasma zinc, copper and iron 
Plasma samples were diluted 1:4 with deionized water to get a den­
sity approximately equal to those of the aqueous standards (68). A 
Unicam SP.90 atomic absorption spectrophotometer was used. Diluted 
samples were aspirated directly into the flame. Instructions in the 
manufacturer's manual (69) were closely followed. Zinc, copper and 
iron were analyzed using a flame of either airracetylene (5 liters: 
1 liter)/min or air;propane (5 liters: 0.5 liters/min.). Absorption 
wavelengths were 214.8, 324,8, 248.3 mm, respectively. These were 
the most sensitive absorption lines (70, 71). 
Since plasma copper was not concentrated by extraction, (70), a 
scale expansion procedure for the SP.90 was used to increase the sensitiv­
ity of measurement. A 1000 n-g/ml zinc standard from Fisher^ was used for 
the zinc analyses. Iron wire was dissolved in 1:1 HNO^ and made to 
volume with deionized water for the 1 mg/ml iron standard. Copper metal 
was dissolved in a minimum volume of conc. HNO^ and diluted with 1% 
KîîO^ to volume to give 1 mg/irl standard. Working standards v:ere nade 
from this stock. 
Plasma alkaline phosphatase 
A 37°C, fifteen-minute incubation method described by Wooton (72), 
was used. It involves a potassium ferricyanide reagent and spectro-
photometric reading at 510 nm. 
^Fisher Scientific Company, Fairlawn, New Jersey, USA. 
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Plasma proteins 
Total protein determinations were done with the Biuret method of 
Weichselbaum (73, 74). Albumin determination followed the procedure 
of Dumas (73), involving bromcresol green. Using literature concentra­
tions of fibrin in rat plasma (75), calculations of per cent globulin 
were made. 
Tissue moisture 
Liver, muscle and mid-brain moisture determinations were made in 
a vacuum oven following a procedure in the A.O.A.C.^ manual (76). 
Tissue zinc. copper, iron and sodium 
All tissue samples were digested in a 1:1 dilution of nitric acid 
according to the method of Slavin et al. (77). Stock standards were 
processed in a manner similar to that for plasma. Enough deionized 
water was used until the same nitric acid/water ratios were obtained 
as in the digested samples. Emission spectrophotometry (68), rather 
than absorption spectrophotoiûctry, was used for sodium analyses. No 
light source lamp was needed. Only airracetylene (5 litres:l liter/ 
min.) was used. The wavelength was 560 mm. Generally, a higher level 
of digest dilution was needed to get samples within the linear range 
of the instrument. 
^Association of Official Analytical Chemists. 
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Liver protein 
Liver protein determinations were done with a fast semi-
automated microkjeldahl procedure (78). It allowed a maximum of 
nine samples to be run simultaneously in duplicates. 
Urine creatinine 
Previously freeze-dried urine samples, representing 72 hours urine 
excretions, were dissolved in deionized water. To get reasonably high 
creatinine concentrations, the minimum volume of water possible was 
used. Creatinine determinations were done with a method described by 
Wooton (72). 
Statistical analyses 
Results of each experiment were analyzed with the General Linear 
Model (GLM) regression procedure used in the SAS computer program 
system (79). Mean values were further compared by the PROG TTEST (i.e., 
t-test) procedure of the SAS system (80). Correlation analyses were 
also done using the same program system. 
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RESULTS 
Experiment I 
The experiment was designed to find out how long it would take to 
induce kwashiorkor, using the low-protein diets. It was also to check 
the effect of different dietary zinc concentrations on PEM development 
and to follow the entire course of the disease until death. 
Development of kwashiorkor symptoms 
Lower food and water intakes (Table 4 and Figure 1) became ap­
parent among the low dietary protein rats (LPLZ and LPHZ) before the 
end of the first week of feeding. By the end of that week, the food 
intake of the high protein rats (HPLZ and HPHZ) was significantly 
higher (p < 0.05) than that of the low protein rats. There was a 
nonsignificantJ but slightly better food intake by the LPLZ rats compared 
with the LPHZ rats until the 3rd week when a reversal occurred. 
Body-weight changes followed the food-intake patterns closely. 
Body weights of both low-protein groups fell continuously until an 
approximate minimum of 31.0 gm per animal had been reached on the 5th 
week (Table 5 and Figure 2). There was a slightly faster weight loss 
by the LPHZ as compared to LPLZ group. In the 3rd week, LPLZ body weights 
began falling fast until they matched the LPHZ weights. 
By the end of the first week, the high protein rats (which had been 
gaining weight) were significantly (p < 0.05) heavier than the low 
protein rats. By the 6th week, HPHZ and HPLZ rats, respectively, weighed 
about 10 and 7 times more than the LP rats.' 
Table 4. Cumulative food intake of rats (Experiment I: depletion) 
Dietary treatment 
# of 
rats Week 1 Week 2 Week 3 Week 6 
LPLZ - 1 4 28.2 + 1.7 
a gm 50.6 + 3.6 71.0 ± 6.3 124.6 + 13.6 
LPLZ - 2 5 27.7 + 2.3 gm 49.8 + 4.3 73.8 + 5.7 142.3 + 12.1 
HPLZ - 3 7 59.4 + 3.0 119.0+5.9 181.1 + 8.5 421.4 ± 25.2 
Control (HPHZ) — 4 8 62.5 + 3.2 141.6 + 7.3 234.8 + 10.7 540.1 H; 21.1 
T-test comparison between 
LP treatments 
HP treatments 
NS 
NS 
NS 
it 
NS 
A* 
NS 
•ki< 
Significant dietary effect 
(P<0.05)b 
Pr only Pr only Pr (major 
effect) 
Z 
Pr X Z 
Pr (major 
effect) 
Z 
Pr X Z 
^ean + SEM (No. of rats). 
^Pr = dietary protein; Z = dietary zinc; Pr x Z = interaction. 
CUMULATIVE FOOD INTAKES 
HPHZ 
HPLZ 
_LPHZ 
LPLZ 
4 5 
WEEKS ON DIET 
Figure 1. Cumulative fopd intake. Dietary zinc effect, on food Intake was not significant until 
after 2 weeks depletion 
to \D 
Table 5. Body weight of rats (Experiment I: depletion) 
1st week 2nd week 3rd week At death 
Dietary treatments 0 day 2 days (9 days) (16 days) (45-84 days) 
LPLZ - 1 52.8 + 4.4* 
(9) 
56.1 + 2, 
(9) 
,0 46.7 +2.1 
(9) 
41.5 + 1, 
(9) 
7 31,8 + 1.0 
(9) 
LPHZ - 2 53.4 + 4.2 
(8) 
48,5 + 2. 
(8) 
,6 43.4 + 2.7 
(8) 
36.3+ 1. 
(8) 
,8 31,0 + 2,3 
(8) 
HPLZ - 3 56,0 + 3,6 
(12) 
68,9 + 2. 
(12) 
6 99.6 + 4.0 
(12) 
141,6 + 9. 
(12) 
6 316,7 + 10,8 
(12) 
Control (HPHZ) - 4 53.3 + 2.9 
(10) 
69.3 + 3. 
(10) 
7 115.4 + 7.0 
(10) 
187.9 + 10.5 
(10) 
382.4 + 18.8 
(10) 
T-test comparison between 
LP treatments 
HP treatments 
_ b  A  
NS 
NS 
NS 
NS NS 
** 
Significant dietary effects 
(P < 0.05)c Pr only Pr Pr (major effect) 
Z 
Pr X  Z 
Pr (major 
effect) 
Pr X Z 
^Mean + SEN (No. of rats). 
^No data. 
^Pr = dietary protein; Z = dietary zinc; Pr x Z = interaction. 
^Level of significance = 0.068(). 
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Figure 2. Growth curves. Only dietary protein affected body weight 
changes significantly in first week of feeding (Table 5) 
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Tables 4 and 5 Indicate that the major cause of loss of body weight 
and loss of appetite in the protein-deficient groups was the lack of 
dietary protein. For the first two weeks, no effects of dietary zinc 
deficiency were seen at all. It was in the 3rd week, presumably because 
of depletion of body zinc stores, that dietary zinc effects began to show. 
This led immediately to quick loss of food intake and loss of body weight 
by the LPLZ rats. HPLZ rats also gained weight at a significantly slower 
rate than the control rats. 
A severe reduction in physical activity among both groups of low-
protein rats was seen in the second week. They did not resist any attempt 
to be picked up from their cages. 
In the 3rd week, pronounced hair changes were noticeable among the 
low protein rats. Beginning with LPHZ rats, hair was lost around head and 
eyes. Body hair took on a rough appearance. By the 4th week, there was 
total hair loss on tails of most low dietary protein rats. 
Edema appeared in the 5th week. First among the LPLZ rats and a few 
days later, among the LPHZ rats. The sequence was repeated in Experiments 
II and III. Statistically (Table 22), the difference in day of onset was 
net significant. The edema was characterized by a bloated appearance, 
followed by localized fluid accumulation at the chest, sometimes spreading 
down between the fore legs. Swelling of dorsal surfaces of fore feet was 
noticed in Experiment I. Sometimes slight increases in body weight 
accompanied the edema. The edema sometimes diminished or disappeared 
altogether and reappeared a few days later. 
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of dermatoses among the low protein rats were about 20%. Most dermatosis 
occurred on the dorsal surfaces of the fore paws but a few had it on the' 
tails. Some few severe cases of peeling of large areas of inner sides of 
the fore legs and on the hind legs up towards the thighs were seen. One 
case of skin peeling on the abdomen was seen. It was impossible to decide 
which low-protein group had more skin disorders. 
Severe cases of upward curvature of the spine occurred in both low 
protein groups, after approximately 5 weeks. The same observation was made 
in Experiment II. In depletion studies III and IV, this was not seen. 
Some eye disorders observed by others (30a, 31a) were also seen in this 
experiment and systematically checked in Experiment II. Tie disorders were 
accompanied by keratinization (31b). 
Urine creatinine excretion is known to reflect overall body muscula­
ture (81). The data in Table 6 suggest that the PEM (i.e., low dietary 
protein) rats excreted significantly (p _< 0.05) less urinary creatinine 
than the high protein rats. The high protein rats on low zinc (HPLZ) 
excrctcd significantly (p _< 0.01) less creatinine than the control? 
(HPHZ). Among the PEM rats, LPHZ excreted numerically (but not 
statistically significantly) lower amounts of creatinine. Dietary protein, 
zinc and their interactions show equal effects on the creatinine excre­
tion at this 7th week of study. The low-protein rats had significantly 
lower body length and creatinine/body length ratios. Dietary protein 
effects are the major causative factor. 
Body, liver, spleen and kidney weights were significantly lower 
among the PEM (i.e., LPLZ and LPHZ) rats (Table 7). There was also a 
significant (p _< 0.01) difference between the body, liver and kidney 
Table 6. Body length and urine creatinine of rats after 35 days on diet (Experiment I: depletion) 
Dietary treatment 
Urine creatinine 
(mg/dl) 
Body length 
(cm) 
Creatinine 
Body length ° 
LPLZ - 1 1.4 + 0.13* 
(9) 
13.7 + 0.21^ 
(9) 
0.07 + 0.01 
(9) 
LPHZ - 2 0.68 + 0.09 
(9) 
13.2 + 0.25 
(9) 
0.05 + 0.01 
(9) 
HPLZ - 3 5,32 + 0.41 
(12) 
20.5 + 0.23 
(12) 
0.26 + 0.02 
(12) 
Control (HPHZ) - 4 9.35 + 0.74 
(13) 
22.4 + 0,31 
(13) 
0.41 + 0.03 
(13) 
T-test comparison between 
LP treatments 
HP treatments 
NS 
•k* 
NS 
A* 
NS 
*>•< 
Significant dietary effects 
(P < 0.05)3 
Equal effects of 
Pr 
Z 
Pr x Z 
Pr Major 
Pr X Z effects 
Z 
Pr Major 
Pr X Z effects 
Z 
^Mean + SEK (No. of rats). 
'^Distance from tip of nose to base of tall. Tall tips excluded for this study because of 
necrosis. 
"^Pr = dietary protein; Z = dietary zinc; Pr x Z = Interaction. 
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Figure 3. (A) Treatment 2 (LPHZ) sliowed significantly earlier mortality than treatment 1 (LPLZ) 
in Experiment x. (B-D) Significantly different values for high-protein rates (Table 6) 
Table 7. Fresh organ weights and organ/body weight ratios of rats at 
death (Experiment I : depletion) 
Body Liver 
weight Weight Liver 
Dietary treatments (gm) (gm) Body wt. 
LPLZ - 1 31.8 + 1.0^ 0.93 + 0.04 0. 03 + 0.00 
(9) (9) (9) 
LPHZ - 2 31.0 + 22.3 0.95 + 0.10 0, ,03 + 0.00 
(8) (7) (7) 
HPLZ - 3 316.7 + 10.8 10.0 + 0.62 0. 03 + 0.00 
(12) (12) (12) 
Control (HPHZ) - 4 386.5 + 17.9 13.4 + 0.41 0, .04 + 0.00 
(13) (13) (13) 
T-test comparison between 
LP treatments NS NS NS 
HP treatments Aft ft* NS 
Significant dietary effects Pr (Major (Major Pr only 
(P < 0.05)% effect) effect) 
Z Z 
Pr X Z Pr X Z 
^ean + S EM (No. of rats). 
Pr = dietary protein; Z = dietary zinc; Pr x Z = interaction. 
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Spleen Kidney 
Weight Spleen Weight Kidney 
(gm) Body wt. (gm) Body wt. 
0. 02 + 0.01 0.0007 0.44 + 0.02 0. 014 + 0.000 
(9) (9) (9) (9) 
0. 04 + 0.01 0.0013 0.46 + 0.04 0. ,014 + 0.000 
(5) (5) (5) (5) 
0. 56 + 0.04 0.0018 2.13 + 0.07 0. ,007 + 0.000 
(12) (12) (12) (12) 
0. ,63 + 0.03 0.0016 2.73 + 0.10 0, ,007 + 0.000 
(12) (12) (12) (12) 
NS NS NS NS 
NS NS ** NS 
Pr only Pr (Major T"]: (Mai or Pr only 
effect) effect) 
Pr X Z Z 
Pr X Z 
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Skin disorders were noticed. Most incidences of dyspigmentation 
were noticed on the tails. Lesions on tails were also seen. While 
liver/body weight, and spleen/body weight ratios were significantly 
(p £ 0.05) lower in the PEM rats, their kidney/body weight ratios were 
significantly higher than in the high protein rats. The differences in 
organ weights and organ/body weight ratios are mainly an effect of 
dietary protein level. 
After 2 days on diet, there was a slightly numerically higher (NS)^ 
plasma alkaline phosphatase for the high-protein rats. After 9 days 
(Table 9), there was still no significant difference between the low 
protein rats and high protein rats. The rats on high zinc (regardless of 
dietary protein), however, did not show significantly higher alkaline 
phosphatase. In Table 10, after 84 days, there was still no significant 
difference between alkaline phosphatase levels of the high protein rats. 
Level of zinc deficiency (6 ppm) induced in these studies was not severe. 
For both alkaline phosphatase and copper (Table 8), plasma levels were not 
significantly different between any of the four treatments. HPLZ rats were 
the first to show significantly depressed plasma zinc concentration. After 
9 days (Table 9), plasma zinc had fallen significantly in all groups except 
the control (i.e., HPHZ). The PEM rats fed high zinc (LPHZ) had signifi­
cantly (p £ 0.01) higher levels than LPLZ. The controls had significantly 
(p j< 0.01) higher levels than HPLZ. Dietary protein, zinc and Pr x Z 
interactions equally affect the plasma zinc concentrations. 
^Not significant. 
Table 8. Plasma concentration of alkaline phosphatase, zinc and copper of rats after 2 days on 
diets (Experiment I: depletion) 
Alkaline phosphatase Zinc Copper 
Dietary treatment (KAU%)a (M-g/ml) (iig/ml) 
LPLZ - 1 48.7 + 7.9^ 2,52 + 0.14 
_c 
(9) (5) 
LPHZ - 2 46.3 + 8.1 2,03 + 0,21 1.58 + 0.07 
(8) (7) (4) 
HPLZ - 3 54.7 + 4.5 1,37 + 0,09 1.63 + 0.09 
(12) (12) (10) 
Control (HPHZ) — 4 54.2 + 7.6 2.50 + 0.21 1.58 + 0.08 
(10) (9) (10) 
T-test comparison between 
LP treatments NS NS — 
HP treatments NS ** NS 
Significant dietary effects No sig. Pr Pr X Z No sig. Pr 
(P < 0.05)d or Z effects or Z effects 
^King Armstrong Units/100 ml plasma. 
^Mean + SEM (No. of rats). 
^No data. 
^Pr = dietary zinc; Z = dietar) zinc; Pr x Z = interaction. 
PLASMA ALKALINE PHOSPHATASE 
LPH?;. 
LPLZ 
HPHZ 
- HPLZ 
a. L 
3 5 7 -ih-
J L 
78 80 82 04 
DAYS ON DIET 
4.  Plasma alkaline phosphatase on days 2 and 9 for LP rats and days 2, 9 and 84 for HP rats, 
Decreasing levels with age confirm literature (Tables 8-10) 
Table 9. Plasma concentration of alkaline phosphatase, zinc, proteins 
and copper of rats after 9 days on diet (Experiment I: 
depletion) 
Dietary treatment 
Alkaline 
phosphatase 
(KAU%) 
Zinc 
(•Ag/ml) 
LPLZ - 1 56.8 + 3.8^ 
(9) 
0.84 + 0.05 
(9) 
LPHZ - 2 66.5 + 6.6 
(9) 
1.34 + 0.14 
(9) 
HPLZ - 3 54.6 + 3.9 
(12) 
1.0 + 0.04 
(12) 
Control (KPHZ) — 4 61.5 + 6.9 
(13) 
2.66 + 0.15 
(13) 
T-test comparison between 
LP treatments 
HP treatments 
NS 
** 
** 
•k* 
Significant dietary effects 
(P < 0.05)^ 
No sig. Pr 
or Z effects 
Pr 
Z 
Pr X Z 
^Mean -t- SEfri (Ino. of rats). 
^Pr = dietary protein; Z = dietary zinc; Pr x Z = interaction. 
'"No data. 
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Proteins (gm/dl) Copper 
Total Albumin Globulin A/G ratio (M-g/ml) 
5.82 + 0.18 
(9) 
4.74 + 0.29 
(9) 
6.42 + 0.15 
(12) 
6.35 + 0.12 
(13) 
2.87 ± 0.09 
(9) 
2.75 + 0.21 
(9) 
3.96 + 0.09 
(12) 
3.86 + 0.12 
(13) 
2.71 ± 0.20 
(9) 
1.80 + 0.10 
(9) 
2.20 ±  0 .12 
(12) 
2.30 + 0.14 
(13) 
1.11 + 0.09 
(9) 
1.55 + 0.12 
(9) 
1.86 + 0.12 
(12) 
1.84 + 0.18 
(13) 
1.24 + 0.06 
(12) 
1.24 + 0.06 
(13) 
NS 
NS 
•k 
** 
NS NS 
NS 
NS 
Pr (Major Pr only Z Pr only No sig. Pr 
effect) Pr (Major or Z effects 
Z effect) 
PLASMA PROTEINS (9 DAYS ON DIET) 
A/G RATIO 
TOTAL 
PROTEIN 
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•igure 5. Significantly different plasma protein levels in A, C, and D for low protein rats and 
in B for high-protein rats (Table 9) 
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High dietary protein rats had significantly higher plasma protein 
contents than the PEM rats. Main effects here are dietary protein. In 
the case of plasma globulin, there is a Pr x Z main effect. The LPHZ rats 
had a significantly (p ^  0.01) lower plasma total protein and globulin and 
also lower (NS) albumin than the LPLZ rats. The A/G (Albumin/Globulin) 
ratio had the same pattern between them. 
Again, no dietary effects were seen on plasma copper either on the 
9th day (Table 9) or 84th day (Table 10) of the study. 
A different picture emerges for copper in the liver (Table 11). 
Dietary effects were seen on the liver copper concentrations as compared 
with plasma (Tables 8, 9, 10). The LPLZ rats had significantly higher 
(p ^  0.05) concentrations than the LPHZ rats. Since the LPLZ rats had 
significantly lower liver weights, their total liver copper concentrations 
were significantly lower than for the high dietary protein rats. 
There was a significantly higher concentration of moisture in the 
livers of the PEN rats. This condition seems to be due mainly to dif­
ferences in dietary protein. 
On a wet weight basis, livers of PEM rats had significantly lower 
protein levels (gm/100 gm). A check on Experiment IV (Table 33), showed 
a dietary protein effect also on a dry weight basis. 
Just as in the case of copper (.Table 11) , the PEM rats had 
significantly higher liver zinc and iron concentrations (jjg/gm) . 
Regardless of dietary protein levels, the rats fed low zinc had 
significantly (pj<0.05) higher liver iron concentrations. For the rats 
fed high protein, this picture was repeated in Experiment III 
Table 10. Plasma alkaline phosphatase, zinc, copper and proteins of 
rats after 84 days (Experiment I: depletion) 
Dietary treatment 
Alkaline 
phosphatase 
(KAU7o) 
Zinc 
(^ g/ml) 
Copper 
(tig/ml) 
HPLZ - 3 
Control (HPHZ) - 4 
26.2 + 2.1* 
(12) 
30.2 + 1.8 
(13) 
1.46 + 0.11 
(12) 
2.69 + 0.11 
(13) 
1.38 + 0.05 
(12) 
1.47 + 0.09 
(13) 
T-test comparison between 
HP treatments NS ** NS 
Significant dietary effects 
(P < 0.05)b 
No sig. Pr 
or Z effects 
Z only No sig. Pr 
or Z effects 
e^an + S EM (No. of rats). 
P^r = dietary protein; Z = dietary zinc. 
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Proteins (gm/dl) 
Total Albumin Globulin A/G ratio 
7.97 + 0. 16 4.30 + 0.13 3.35 + 0.15 1.32 + 0.08 
(12) (12) (12) (12) 
8.89 + 0. 30 4.55 + 0.11 3.99 + 0.30 1.20 + 0.08 
(13) (13) (13) (13) 
* NS NS NS 
Z No sig. 
Z effect 
No sig. 
Z effect 
No sig. 
Z effect 
Table 11. Liver protein and copper of rats at death (Experiment I: 
depletion) 
Dietary treatment 
Wet liver 
weight 
(gm) 
% liver 
moisture 
LPLZ - 1 0.93 + 0.04^  80.9 + 1.8 
(9) (11) 
LPHZ - 2 0.95 + 0.11 
(7) 
80.1 + 0.9 
(10) 
HPLZ - 3 10.1 + 0.6 
(12) 
67.5 + 1.4 
(12) 
Control (HPHZ) - 4 13.4 + 0.4 
(12) 
65.8 + 1.4 
(12) 
T-test comparison between 
LP treatments 
HP treatments 
NS 
NS 
NS 
NS 
Significant dietary effects 
(P < 0.05)c 
Pr (Major 
effect) 
Z 
Pr X Z 
Pr only 
T^aken from Experiment 
HP treatments. 
II for LP treatments; from Experiment I for 
M^ean + S EM. (No. of rats) 
• 
P^r = dietary protein; Z = dietary zinc; Pr X Z = interaction. 
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Protein Copper 
Dry liver Wet liver Total liver Dry liver Wet liver Total liver 
(gm/100 gm) (gm/100 gm) (gm) (ug/gm) (yg/gm) (pg) 
52.6 + 3.0 10.0 + 0.6 0.094 + 0.002 34.4 + 3.5 6.58 + 0.66 6.16 + 0.78 
(9) (9) (9) (9) (9) (9) 
44.2 + 4.4 8.8 + 0,9 0.084 + 0.014 24.4 + 2.2 4.85 + 0.43 4.75 + 0.33 
(7) (7) (7) (6) (6) (6) 
52.3 + 0.6 17.0 + 0.2 1.723 -i- 0.111 14.6 + 0.6 4.73 + 0.18 47.36 + 2.91 
(12) (12) (12) (12) (12) (12) 
48.5 + 0.8 16.6 + 0.3 2.240 + 0.090 16.0 + 1.4 5.46 + 0.47 73.41 + 6.82 
(12) (12) (12) (12) (12) (12) 
NS NS NS ** NS NS 
** NA ** NS NS ** 
Z only Pr only Pr Pr (Major Pr X Z Pr (Major 
Pr X Z effect) effect) 
Z Z 
Pr X Z Pr X Z 
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Figure 6. Liver proteins. Differences significant only for HP rats. In A, B and D (Table 11) 
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Table 12. Liver zinc and iron of rats at death (Experiment II: 
depletion) 
Dietary treatments 
Wet liver 
weight 
(gm) 
% liver^  
moisture 
LPLZ - 1 0.93 + 0.04^  
(9) 
80.9 + 0.9 
(11) 
LPHZ - 2 0.95 + 0.11 
(7) 
80.1 + 0.9 
(10) 
HPLZ - 3 10.1 + 0.6 
(12) 
67.5 + 1.4 
(12) 
Control (HPHZ) - 4 13.5 + 0.4 
(12) 
65.8 + 1.4 
(13) 
T-test comparison between 
LP treatments 
HP treatments 
NS 
** 
NS 
NS 
Significant dietary effects 
(P < 0.05)c 
Pr (Major 
effect) 
Z 
Pr X Z 
Pr only 
a^ta for LP treatments from Experiment II; HP treatment data from 
Experiment I. 
"Mean + SEM (No. of rats). 
P^r = dietary protein; Z = dietary zinc; Pr x Z = interaction. 
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Protein Copper 
Dry liver Wet liver Total liver Dry liver Wet liver Total liver 
(ym/lOO gm) (ym/lOO gm) (urn) (ug/gm) (ug/gm) (Pg) 
211.5+20.0 40.4+3.8 38.0+4.8 2240+242 427.9+46.2 398.0+46,9 
(9) (9) (9) (9) (9) (9) 
135.1+12.0 26.9+2.4 26.0+0.8 1358+103.9 272.7+17.2 271.2+21.5 
(6) (6) (6) (5) (6) (6) 
87+1.4 28.3+0.44 284.8+16.3 382.5+26.5 124.4+8.6 1229.8+78.5 
(12) (12) (12) (12) (12) (12) 
85.6+2.3 29.3+0.9 394.0+15.1 306.7+17.0 104.2+5.8 1401.2+79.3 
(12) (12) (12) (12) (12) (12) 
* NS * * NS 
NS NS ** * NS NS 
Pr (Major Pr Pr (Major Pr (Major Pr (Major Pr (Major 
effect) Z effect) effect) effect) effect) 
Z Pr (Major Z Z Z Z 
Pr X Z effect) Pr X Z pr X Z Pr X Z Pr X Z 
LIVER ZINC OF RATS AT DEATH 
cc 
UJ 
> 
% 
o 
o 
z 
N 
cn 
3 
220 
180 
140 
100 
60 
20 
T DRY LIVER 
A 
1 
1234 
W E T  L I V E R  
B 
450 
0)350 
3 
<250 
o 
H 150 
50 
TOTAL LIVER 
C 
w 
f 234 
i 
Ut 
N) 
I 234 
TREATMENTS 
cm LOW PROTEIN 1^ HIGH PROTEIN 
Figure 7. Liver zinc. Significantly different values in A and B for LP rats and in C for HP rats 
(Table 12) 
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Figure 8. Liver iron. Significantly different for LP rats in A and B. Significantly different for 
HP rats in A (Table 12) 
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(Tables 16, 17, 19) for muscle, liver and brain. It was confirmed again 
in Experiment IV (Table 29) where perfused livers were examined. 
Dietary protein effects were mainly responsible for the differences in 
liver iron and zinc. Dietary zinc and Pr x Z effects were present but 
secondary. 
The concentrations (pg/gm) of minerals - zinc,' copper and iron -
in the liver showed significant negative correlations (-0.74, -0.71, 
-0.84, respectively) with body weight. They show a similar relation­
ship (-0.77, -0.75, -0.87 for zinc, copper, iron, respectively) with 
dietary protein. The picture is the same for their relationship with 
liver protein. Iron showed the highest negative correlation in these 
instances. Iron did the same in Experiment III (Table 21). 
Concentrations (ug/gm) of the minerals also correlated negatively 
with their respective total liver concentrations. Thus, for yg/gm 
mineral vs. total yg mineral, r is -0.69, -0.63, -0.64 for zinc, copper 
and iron, respectively. 
From the weeks 6-8, about 70% of the PEM rats (LPLZ and LPHZ 
combined) died. No deaths occurred among high protein rats. This was 
due apparently to dietary protein differences. Zinc did have some 
secondary effect in causing significantly (p _< 0.01) earlier deaths 
among the PEM rats fed high dietary zinc (LPHZ). On the average, the 
LPHZ rats died two weeks earlier than the LPLZ rats. By the 84th day 
of the study (12 weeks) no death had occurred among the rats fed high 
protein regardless of the dietary zinc level. The zinc deficiency 
induced in this study (6 ppm dietary zinc) was moderate. 
Table 13. Liver correlation coefficients (r-values) from rats. Only 
values >0.5 are reported (except for liver protein). Level 
of significance in all cases = 0.0001 (in range = 36-41. 
Experiment I: depletion) 
Wet 
Body liver Zinc Copper 
Variable wt. wt. Wb D W 
Dietary protein 0.96 0.94 -0.77 -0.75 
Dietary zinc 
Body weight 
Wet liver weight 
Zinc (dry) 
Zinc (wet) 
Copper (dry) 
Copper (wet) 
Iron (dry) 
Iron (wet) 
Total zinc 
-0.74 — -0.71 — 
-0.74 - -0.70 
0.93 0.63 
— — — 0.75 
D^ = dry liver. 
W^ = wet liver. 
N^ot significant. 
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Protein 
Iron (gm/100 gm) Total Total Total Total 
W D W zinc copper iron (gm) 
-0.87 -0.83 O.lic 0.93 0.93 0.84 0.90 0.94 
-0.84 -0.81 0.09 0.90 0.90 0.88 0.90 0.98 
-0.83 -0.81 - 0.88 0.98 0.91 0.92 1.00 
0.87 0.86 - -0.64 -0.69 -0.63 -0.64 -0.74 
0.62 0.63 — — — — — — 
0.81 0.79 - -0.66 -0.65 - -0.63 -0.71 
- - - -0.72 -0.81 -0.74 -0.70 -0.83 
- - - -0,66 - -0.71 - -0.80 
-0.78 - 0.87 - - 0.91 0.98 
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Figure 9. Regression relationships between body-weight, total zinc 
and other liver parameters (Table 13) 
Table 14. Muscle moisture; number of days on diet before death; muscle 
zinc and iron of rats at death (Experiment I: depletion) 
% No. of days 
muscle before 
Dietary treatment moisture death 
LPLZ - 1 71.7 + 1.5^  59.8 + 2.6 
(9) (9) 
LPHZ - 2 75.0 + 1.3 45.5 + 2.3 
(7) (8) 
HPLZ - 3 71.5 + 0.7 No deaths 
(10) (12) 
HPHZ - 4 71.4 + 0.6 No deaths 
(9) (12) 
T-test comparison between 
LP treatments NS ** 
HP treatments NS NS 
Significant dietary effects No sig. Pr (Major 
(P < 0.05)C dietary effect) 
effects Z 
Pr % Z 
D^ata from Experiment II for LP and Experiment I for HP. 
M^ean + SEM (No. of rats) 
• 
P^r = dietary protein; Z = dietary zinc; Pr x Z • = interaction. 
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Zinc Iron 
Dry muscle Wet muscle Dry muscle Wet muscle 
( g/gm) ( g/gm) ( g/gm) ( g/gm) 
66,0 + 16.3 48.6 + 4.8 337.9 + 21.3 99.0 + 6.2 
(9) (9) (8) (8) 
26.4 + 14.3 32.7 + 3.7 332.3 + 38.3 86.1 + 10.1 
(7) (7) (7) (7) 
53.0 + 1.5 15.2 + 0.4 121.5 + 29 34.5 + 0.8 
(12) (12) (12) (12) 
63.0 + 3.6 18.0 + 1.0 123.4 + 2.6 35.6 + 0.7 
(10) (10) (9) (9) 
NS * NS NS 
* * NS NS 
Pr (Major 
effect) 
Pr X Z 
Pr (Major 
effect) 
Z 
Pr only Pr only 
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muscle iron differences (Table 14) 
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Muscle moisture, on the average, was the same in all treatments. 
No significant dietary effects occurred. 
Significantly higher muscle zinc and iron concentrations occurred 
among the PEM rats compared to all others. In adequate dietary protein 
groups, muscle zinc concentration was significantly (p _< 0.05) lower in 
the rats on low zinc. 
Experiment II 
This study was undertaken to find the effects of dietary zinc on 
survival rate during PEM. The course of development of PEM in this 
study was generally the same as for Experiment I. Only low protein 
diets (LPLZ and LPHZ) were used. 
Eye disorders 
Eye disorders occurred among both groups of PEM rats. Histologically, 
keratinization of the corneal and conjunctival epithelium is characteristic 
of xerophthalmia. Xerophthalmia is caused primarily by hypovitaminosis 
A. A degree of protein malnutrition is believed to be present (as in 
the case of our LP rats) when ocular symptoms develop (31b). In the 
presence of severe protein deficiency, xerophthalmia can be followed 
by keratomalacia. This is a severe ulceration of the cornea. If our 
LP rats had low plasma vitamin A - a possibility which wasn't checked -
then the right conditions were present for keratomalacia. Fifty per cent 
of the LPLZ rats developed some eye disorder during the study. Nine 
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(i.e., 30%) of the 30 LPLZ rats had a total closure of one or both 
eyes at the end of the study. 
Those fed high zinc had a lower incidence of eye disorders. The 
disorders were less serious in the LPHZ group. Altogether, 3 out of 
the 30 rats had a total closure of one eye or both at the end of the 
study. 
Between the two PEM groups (Tables 22-23) death began one week 
earlier among the LPHZ rats. This time difference was not statistically 
significant. Deaths started 2 weeks earlier (Table 14) among the same 
LPHZ group in Study I. That was statistically significant. 
Liver and muscle moisture were not significantly different between 
the low protein groups. 
Experiment III 
This study was conducted for exactly five weeks to check some of the 
findings of Experiment I. The brain, which was not looked at in Experiment 
I, was examined in this study. Following a report (82) of an effect of 
zinc on sodium transport in leucocytes during PEM, tissue sodium was also 
examined in this study. 
As in Experiment I (Table 9), the PEM rats (Table 15) had signifi­
cantly lower plasma proteins. In this as in the other two studies 
(Tables 9 and 25), dietary zinc had no significant effect on plasma 
albumin. Dietary zinc in all cases had a significant secondary effect 
on plasma globulin concentrations. 
Table 15. Plasma proteins after 5 weeks on diet (Experiment III: depletion) 
Total protein Albumin Globulin 
Dietary treatment (gm/dl) (gm/dl) (gm/dl) A/G ratio 
LPLZ - 1 2.34 H- 0.17^  1. 37 + 0.13 0.87 + 0.23 5.9 + 2.3 
(10) (10) (10) (10) 
LPHZ - 2 1.84 4- 0,16 1. 29 + 0.12 0.47 + 0.11 3.6 + 1.4 
(!)) (9) (9) (8) 
HPLZ - 3 4.77 4- 0.27 3. 02 + 0.07 1.56 + 0.29 3,0 + 0.8 
(')) (9) (9) (9) 
Control (HPHZ) — 4 4.21 0.12 3. 00 + 0,06 1.02 + 0.13 3,6 + 0,5 
(11) (11) (11) (11) 
T-test comparison between 
• LP treatments s NS NS NS 
• HP treatments Ni; NS NS NS 
Significant dietary effects Pr (Major effect) Pr only Pr (Major effect) No sig. 
(P< 0.05)b Z Z dietary effects 
M^ean + SEM (No. of rats). 
P^r = dietairy protein; Z = dietary zinc. 
Table 16. Body weight, muscle zinc, iron, moisture and sodium after 
5 weeks on diets (Experiment III: depletion) 
Dietary 
treatments 
Body 
wt. 
(gm) 
7o 
muscle 
«2° 
Dry 
muscle 
(Mg/gm) 
Zinc 
Wet 
muscle 
(p,g/gm) 
LPLZ - 1 32. 0 + 0. 71.7 + 1. 5 80.5 + 3, .3 23.6 + 1. 0 
(6) (10) (12) (12) 
LPHZ - 2 32. 3 + 1. ,0 75.0 + 1. 3 86.6 + 5, .6 22.4 + 1. 4 
(6) (7) (12) (12) 
HPLZ - 3 124 .5 + 7, .9 71.5 + 0. 7 58.5 + 3 .3 16.7 + 0. .9 
(6) (10) (12) (12) 
Control (HPHZ) — 4 208 .2 + 7. 9 71.4 + 0, .0 57.7 + 2 .4 16.4 T 0. ,7 
(6) (9) (12) (12) 
T-test comparison 
between 
• LP treatments 
» IIP treatments 
NS 
** 
NS 
NS 
NS 
NS 
NS 
NS 
Significant dietary Equal effects Pr only Pr only Pr only 
effects of 
(P < 0.05)C Pr 
z 
Pr X Z 
M^ean + SEM (No. of rats). 
P^r = dietary protein; Z = dietary zinc; Pr x Z = interaction. 
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Iron Sodium 
Dry Wet Dry Wet 
muscle muscle muscle muscle 
(ng/gm) (P-g/gm) (tig/gm) (ng/gm) 
210.0 + 12.3 61.6 4- 3.6 2.44 + 0.10 0.71 + 0.03 
(12) (12) (12) (12) 
199.2 + 10.1 51.6 + 2.6 2.57 + 0.19 0.67 + 0.05 
(12) (12) (12) (12) 
123.5 + 6.4 35.2 + 1.8 1.59 + 0.06 0.45 + 0.02 
(12) (12) (12) (12) 
111.8 +5.4 32.0 4- 1.5 1.39 + 0.04 0.40 -!- 0.01 
(12) (12) (12) (12) 
NS * NS NS 
NS NS * * 
Pr only Pr (Major effect) Pr only 
Z 
Pr only 
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As in Experiment I (Table 9) and Experiment IV (Table 25), PEN 
rats fed high zinc had the lowest plasma protein concentrations. 
No significant differenqes occurred between plasma protein concentration 
of control and the HPLZ rats. 
Table 16 corresponds with Table 14 of Experiment I. The same 
muscle moisture patterns in Table 14 can be seen here. Confirming 
Experiment I, zinc and iron concentrations of muscle were significantly 
(p ^  0.05) higher in the PEN rats. The highest muscle iron concentrations 
occurred with the rats fed low dietary zinc, reflecting trends seen in 
Tables 12 and 14 for liver and muscle. The same pattern occurred in the 
brain (Table 19). 
There were significantly higher muscle sodium concentrations among 
the PEN rats (Table 12). In the presence of adequate dietary protein, 
rats fed low dietary zinc had the highest muscle sodium concentrations. 
The same occurred for liver (Table 18) and brain (Table 19) . This was 
further confirmed in Experiment IV (Table 33). A similar relationship 
between sodium and zinc occurred with iron and zinc. 
Nost of the data (Table 19) and in Table 18 have been referred to 
in connection with Tables 12 and 16. 
The PEN rats (LPLZ and LPHZ) had significantly (p £ 0.05) lower 
mid-brain weights than those fed high protein diets. While control total 
liver weights in Experiments I, III and IV (Tables 12, 18, 33) were 
5-13 fold higher than livers of PEN rats, mid-brain weights in Table 15 
are less than 1.5 fold bigger in controls than in PEN rats, suggesting 
much faster 
Table 17. Liver weight, moisture, zinc, and iron after 5 weeks on diet 
(Experiment III; depletion) 
Dietary 
treatments 
Wet liver 
weight 
(gm) 
% liver 
moisture 
LPLZ - 1 1.57 + 0.08^  
(12) 
80.9 + 0.9 
(11) 
LPHZ - 2 1.45 + 0.06 
(12) 
80.1 + 0.9 
(10) 
HPLZ - 3 4.51 + 0.24 
(12) 
67.5 + 1.4 
(12) 
Control (HPHZ) - 4 7.60 + 0.49 
(12) 
65.8 + 1.4 
(13) 
T-test comparison between 
LP treatments 
HP treatments 
NS 
** 
NS 
NS 
Significant dietary effects 
(P < 0.05)b 
Equal effects 
of 
Pr 
Z 
Pr X Z 
Pr only 
M^ean + SEN (No. of rats). 
P^r = dietary protein, 2 = dietary zinc; Pr x Z = Interaction. 
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Zinc Iron 
Dry Wet Total Dry Wet Total 
liver liver liver liver liver liver 
(yg/gm) (pg/gm) (ug) (pg/gm) (ug/gm) (yg) 
139.8 + 10.3 26.7 + 2.0 43.0 + 4.7 1. ,09 + 0. 10 0. 21 + 0. 02 0. 31 + 0. 02 
(12) (12) (12) (8) (8) (8) 
136.2 + 9.1 27.1 + 1.8 40.1 + 4.2 1. 06 + 0. 05 0, ,21 + 0. 01 0, .30 + 0. 02 
(12) (12) (12) (10) (10) (10) 
86.2 + 4.0 28.0 + 1.3 125.5 + 6.1 0. 23 + 0. 03 0. 08 + 0. 01 0 .35 + 0. ,05 
(12) (12) (12) (9) (9) (9) 
100.7 + 6.0 34.4 + 2.0 268.1 + 28.4 0 .16 + 0. 01 0, .05 + 0. ,0 0 .40 + 0, .02 
(12) (12) (12) (11) (11) (11) 
NS NS NS NS NS NS 
NS * ** A * NS 
Pr only Pr only Equal Pr only Pr only Pr only 
effects of 
Z 
Pr X Z 
Table 18. Liver weight, moisture and sodium after 5 weeks on diet (Experiment III: depletion) 
Wet liver Sodium 
Dietary 
treatments 
weight 
(gm) 
% liver^  
moisture 
Dry liver 
(mg/gm) 
Wet liver 
(mg/gm) 
Total liver 
(rag) 
LPLZ - 1 1.57 + 0.08^  
(12) 
80.9 + 1.8 
(11) 
5.17 + 0.45 
(8) 
0.99 + 0.09 
(8) 
1.67 + 0.14 
(8) 
LPHZ - 2 1.45 + 0.06 
(12) 
80.1 + 0.09 
(10) 
4.59 + 0.31 
(7) 
0.91 + 0.06 
(7) 
1.46 + 0.10 
(7) 
HPLZ - 3 4.51 + 0.24 
(12) 
67.5 + 1.4 
(12) 
2.16 + 0.07 
(11) 
0.70 -f 0.02 
(11) 
3.15 + 0.22 
(11) 
Control (HPHZ) - 4 7.60 ± 0.49 
(12) 
65.8 + 1.4 
(13) 
1.93 0.05 
(12) 
0.66 + 0.02 
(12) 
5.05 4- 0.40 
(12) 
T-test comparison 
between 
• LP treatments 
• HP treatments 
NS NS 
NS 
NS 
A* 
NS 
NS 
NS 
** 
Significant dietary 
effects 
(P < 0.05f 
Equal effects of 
Pr 
Z 
Pr X Z 
Pr only Pr only Pr only Pr (Major effect) 
Z 
Pr X Z 
L^P data from Experiment II; HP data from Experiment I. 
M^ean + SEM (No. of rats). 
= dietary protein; Z = dietary zinc; Pr x Z = interaction. 
Table 19. Mid-brain weight, moisture, zinc and iron after 5 weeks on 
diet (Experiment III: depletion) 
Dietary 
treatments 
Wet 
mid-brain 
weight 
(gm) 
% 
brain 
moisture 
LPLZ - 1 1.08 + 0.04^  
(11) 
81.0 + 0.68 
(6) 
LPHZ - 2 1.06 + 0.03 
(11) 
79.7 + 0.62 
(6) 
HPLZ - 3 1.21 + 0.04 
(12) 
80.7 + 0.99 
(6) 
Control (HPHZ) - 4 1.37 + 0.04 
(12) 
80.3 + 0.80 
(6) 
T-test comparison between 
LP treatments 
HP treatments 
NS 
* 
NS 
NS 
Significant dietary effects 
(P < 0.05) 
Pr (Major 
effect) 
Pr X Z 
No sig. 
Pr or Z 
effects 
e^an + S EM (No. of rats). 
P^r = dietary protein; Z = dietary zinc; Pr x Z = interaction. 
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Zinc Iron 
Dry Wet Total Dry Wet Total 
mid-brain mid-brain mid-brain mid-brain mid-brain mid-brain 
(pg/gm) (pg/gm) (pg) (pg/gm) (pg/gm) (pg) 
80. 5 + 1. 9 15. 3 + 0. 4 16. 5 + 0. 51 121. o
 
+
 
H
 
O
 
00
 
23, ,0 + 2. 1 24. 6 + 2. 2 
(12) (12) (11) (12) (12) (11) 
78. 4 + 1. 6 15. 9 + 0. 3 16, .8 + 0. ,36 101. ,4 + 9.0 20 . 6 + 1. 8 21. ,9 + 2. 4 
(12) (12) (11) (12) (12) (11) 
78. 5 + 1. ,4 15. 1 + 0. S 18 . 4 + 0, .64 124, .4 + 5.8 24 .0 + 1. ,1 29, .4 + 2. ,1 
(12) (12) (12) (12) (12) (12) 
82. ,1 + 1. ,7 16. 2 + 0. .3 22 .1 + 0. 90 87 .1 + 8.3 17 .2 + 1. ,6 23, .0 + 1, .9 
(11) (11) (11) (11) (11) (11) 
NS NS NS NS NS NS 
NS * ** ** ** ft 
No sig. Z only Pr (Major Z only Z only Z only 
Pr or Z effect) 
effects Z 
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much faster brain growth than liver growth with attainment of maximum 
brain weight close to the weaning time. 
Brain moisture (as in the muscle) is the same in all treatments, 
with no significant dietary effects on it. More direct main effects 
of dietary zinc were seen in brain than in either the liver or muscle. 
Levels of wet mid-grain zinc and all mid-brain iron concentrations 
responded only to dietary zinc. Compared with liver and muscle, much 
less increase in brain zinc and iron concentrations occurred. On dry 
weight basis, there were no significant differences between zinc 
concentrations of PEM and nonPEM rats. As mentioned in connection with 
Tables 12 and 14, significantly higher brain iron occurs among the rats 
fed low dietary zinc when dietary protein is adequate. 
Total brain sodium (Table 20) was significantly lower in PEM rats 
(LPLZ and LPHZ) compared with the nonPEM rats. In the brain, sodium 
concentration (pg/gm dry wt.) is affected only by dietary zinc. As 
mentioned for muscle and liver (Tables 16 and 18), the higher sodium 
concentrations were in the brains of rats on low dietary zinc. 
Similar to plasma (Tables 8, 9, and 10) but differing from the 
liver (Table 11), brain copper levels (Table 20) were independent 
of dietary protein or zinc. No significant group differences occurred. 
Experiment IV 
This study was undertaken to investigate the effects of zinc-
status in PEM on the rate of recovery from the disease. The initial 
Table 20. Mid-brain weight, moisture, sodium and copper after 5 weeks 
on diet (Experiment III: depletion) 
Dietary 
treatments 
Wet 
mid-brain 
weight 
(gm) 
% 
brain 
moisture 
LPLZ - 1 1.08 + 0.04^ 
(11) 
81.0 + 0.68 
(6) 
LPHZ - 2 1.06 + 0.03 
(11) 
79.7 + 0.62 
(6) 
HPLZ - 3 1.21 + 0.04 
(12) 
80.7 + 0.99 
(8) 
Control (HPHZ) - 4 1.37 + 0.04 
(12) 
80.3 + 0.80 
(6) 
T-test comparison between 
LP treatments 
HP treatments 
NS 
* 
NS 
NS 
Significant dietary effects 
(P £ 0.05)b 
Pr (Major 
effect) 
Pr X Z 
No sig-
Pr or Z 
effects 
^ean + S EM (No. of rats). 
^Pr = dietary protein; Z = dietary zinc; Pr x Z = interaction. 
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Sodium Copper 
Dry Wet Total Dry Wet Total 
mid-brain mid-brain mid-brain mid-brain mid-brain mid-brain 
(mg/g) (mg/g) (mg) (yg/gm) (ug/gm) (yg) 
7.08 + 0.13 1.34 + 0.03 1.44 + 0.04 12.29 + 0.63 2.57 + 0,20 
(12) (12) (11) (12) (11) 
6.72 + 0.20 1.36 + 0.04 1.44 + 0.44 11.55 + 0.83 _ 2.47 + 0.19 
(12) (12) (11) (12) (11) 
7.09 + 0.13 1.37 + 0.03 1.66 + 0.05 10.96 + 0.55 _ 2.57 + 0.16 
(12) (12) (12) (12) (12) 
6.64 + 0.09 1.31 + 0.02 1.78 + 0.07 11.77 + 0.77 _ 3.15 + 0.21 
(11) (11) (11) (11) (11) 
NS NS NS NS NS 
* NS NS NS * 
Z only No sig. Pr only No sig. No sig. 
Pr or Z Pr or Z Pr or Z 
effects effects effects 
Table 21. Liver correlation coefficients (r-values) for rats. Unreported values are < 0.5 or in­
significant (Experiment III: depletion) 
Variables 
Body 
wt. 
Wet 
liver 
wt. 
Zinc 
(r^/gm) 
DÎ 
Iron 
(ij.g/gm) 
D W 
Sodium 
(mg/gm) 
D W 
Total 
zinc 
Total 
iron& 
Total 
sodium 
Dietary 0.90 0.85 -0.65 — -0.94 -0.92 -0.90 -0,70 0.74 0.39^ 0.75 
protein (24)(: (48) (48) (38) (38) (38) (38) (48) (38) (38) 
Dietary — — — — — — — — — — — 
zinc 
Body wt. — — -0.69 — -0.92 -0.91 -0.78 -0.54 0.90 0.34^ 0.93 
(24) (18) (18) (19) (19) (24) (18) (19) 
Wet liver — — -0.43® — -0.85 -0.85 -0.75 -0.59 0.96 0.51 0.97 
wt. (48) (38) (38) (38) (38) (48) (38) (38) 
Zinc D — — — 0.60 — 0.73 — -0.23 -0.05 -0.44 
(W^/gm) 
W 
(38) (38) (48) (38) (38) 
Iron D _ 0.86 -0.75 -0.24 -0.76 
(^g/gm) (28) (38) (38) (28) 
W — — — — — 0.83 — — — — 
(28) 
Sodium D — — — - — — — — — -0.63 -0.25 -0.63 
(mg/gm) (38) (28) (38) 
W '— 
^Poor overall correlations; r <0.5 in all cases. 
^Level of significance = 0.0162. 
'^Value of n. 
^Noc significant. 
^Significant level - 0.0026. 
f D = dry liver; W = wet liver. 
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Table 22. Liver moisture, muscle moisture, days on diet before 
mortality and days on diet before appearance of edema 
(Experiment II: depletion) 
Days on diet Days on diet 
before before % liver % muscle 
mortality edema moisture moisture 
LPLZ 56.41 + 1. 97* 34. ,05 + 1. ,13 81. ,8 + 1.7 71.7 + 1.5 
(22) (21) (10) (10) 
LPHZ 54.26 + 2. ,38 34, .76 + 1, .42 80. ,6 + 1.1 75.0 + 1.3 
(23) (21) (7) (7) 
T-test comparison 
between 
* LP rats NS NS NS NS 
Significant dietary No sig. No sig. No sig. No sig. 
effect Z effect Z effect Z effect Z effect 
(P^ < 0.05)c 
^ean + S EM (No. of rats). 
^Probability. 
^Z = dietary zinc. 
DEATH RATES OF LOW PROTEIN 
RATS TO DIETARY ZiNC 
100 EXPER. ! LPHZ 
LPLZ o 60 
40 
^ 80 LPHZ EXPER. 2 
LPLZ 60 
40 
20 
49 56 S3 23 35 42 
DAYS ON DIET 
21 
Figure 11. Shows effect of dietary zinc on survival rate during PEM. 
Experiment I: Deaths started 2 weeks earlier (significant: 
p< 0.01) in LPHZ group. Experiment II: Deaths started 1 
week earlier in the same group but not significant statis­
tically (Tables 14 and 22) 
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Table 23. Rate of death of rats on low protein in response to dif­
ferent levels of dietary zinc (Experiment II: depletion) 
Days on 
diet 7 14 21 28 35 42 49 56 63 
No. — — — 1 0 4 4 7 5 Total 
dead = 21 
LPLZ 
(27) % 
cumulative - - - 3.7 3.7 18.7 33.3 59.3 77.8 77.8 
mortality 
No. --1112773 Total 
dead = 22 
LPHZ 
(28) % 
cumulative — — 3.6 7.1 10.7 17.9 42.9 67.9 78.6 78.6 
mortality 
Table 24. Body weight data of rats during repletion (Experiment IV: repletion) 
0 day repletion 
Depletion (end of 4 weeks 7 days 14 days 21 days 
diets depletion) repletion repletion repletion 
LPLZ - 1 36.9 + 1.1* 
(6) 
72.6 + 3.2 
(6) 
112.8 + 4.04 
(6) 
151.2 + 4.93 
(5) 
LPHZ - 2 37.5 + 1.6 
(6) 
63.9 + 3.2 
(6) 
117.5 + 8.04 
(6) 
119.8 + 13.0 
(6) 
HPLZ - 3 190.1 + 8.3 
(6) 
237.9 + 9.9 
(6) 
258.2 + 11.77 
(6) 
248.3 + 21.4 
(6) 
Control (HPHZ) — 4 197.7 + 12.1 
(6) 
239.8 + 12.0 
(6) 
253.5 + 17.95 
(6) 
299.3 + 8.3 
(6) 
T-test comparison 
between 
0 LP treatments 
« HP treatments 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
Significant dietary 
effects 
(P^ < 0.05)c 
Pr only Pr only Pr only Pr (Major effect) 
Pr X Z 
^Mean + SEM (No, of rats). 
^Probability. 
"^Pr = dietary protein; Z = dietary zinc; Pr x Z = interaction. 
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I'lgure 12. Rats previously on LPLZ diet gained weight faster during repletion than those 
previously on LPHZ diets (Table 24) 
Table 25. Plasma zinc, iron and proteins of rats after 4 weeks depletion (Experiment IV: 
repletion study) 
Depletion 
diets 
Zinc 
(htg/ml) 
Iron 
(ag/ml) 
Proteins (gm/dl) 
Total Albumin Globulin A/G ratio 
LPLZ - 1 
LPHZ - 2 
HPLZ - 3 
0.84 + 0.06* 3.96 + 1.37 2.37 + 0.05 1.27 + 0.06 1.05 + 0.09 1.29 + 0.18 
(6) (4) (6 )  (6 )  ( 6 )  (6 )  
0.94 + 0.05 6.60 + 0.46 2.19 + 0.10 1.13 + 0.08 0.98 + 0.04 1.15 + 0,08 
( 6 )  ( 6 )  ( 6 )  ( 6 )  (6)  (6) 
0.98+0.12 5 . 7 1 + 0 . 2 9  4.14+0.07 2.27+0.03 1.71+0,05 1,33+0,04 
(4) (5) (6)  (6)  (6) (6)  
Control (HPHZ) - 4 1.80 + 0.09 6.45 + 0.37 4.47 + 0.09 2.32 + 0.08 1.97 + 0.09 1.19 + 0.09 
(6)  (6)  ( 6 )  (6)  (6)  (6)  
T-test comparison 
between 
a LP treatments 
« HP treatments 
NS NS 
NS 
NS 
* 
NS 
ys  
NS 
* 
^lean + SEM (No. of rats) 
b 
Pr -- dietary protein; Z = dietary zinc; Pr x Z = interaction. 
NS 
NS 
Significant dietary Pr (Major Z only Pr (Major Pr only Pr (Major No sig. 
effects Z effect effect) effect) Pr or Z 
(P < 0.05) Pr X Z Pr X Z Pr x Z effects 
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depletion also offered an extra opportunity to recheck some of the 
findings of Experiments I and III. 
There was a faster increase in body weight for the LPLZ rats 
than LPHZ rats during 3 weeks repletion (Table 24 and Figure 12). Only 
significant effects of dietary protein were seen in the first two weeks 
of repletion. A significant Pr x Z interaction occurred in the 3rd 
week of repletion. 
Plasma zinc and protein concentrations here (Table 25) reflect the 
same patterns seen in the depletion studies of Experiments I and III 
(Tables 9 and 15). Plasma proteins were lowest in the LPHZ rats. LPHZ 
rats had a slightly higher (NS) plasma zinc concentration. As in 
Experiment I (Table 9), the plasma zinc differences were due to the 
effects of both dietary protein and zinc. 
Regardless of protein status, rats fed high dietary zinc had 
significantly (p _< 0.05) higher plasma iron concentrations. The highest 
plasma iron levels occurred in the LPHZ rats. This is the direct 
opposite of the effects in tissues. This is the only depletion study 
in which plasma iron was assayed. 
After 3 weeks repletion (Table 28) plasma zinc levels of rats that 
had lower zinc status in PEM, had reached normal concentrations. This 
was significantly higher than that of the LPHZ rats. Plasma protein 
concentrations of both groups of PEM rats had doubled during repletion. 
There were no significant differences between LPLZ and LPHZ rats with 
regard to plasma protein levels. Both PEM groups had attained normal 
Table 26. Plasma zinc, iron, and proteins of rats after 7 days repletion with control (HPHZ) 
diet (Experiment IV: repletion) 
Depletion Zinc Iron Proteins (Rm/dl) 
diets (^g/ml) (iJ-g/ml) Total Albumin Globulin A/G ratio 
LPLZ - 1 1 .95 + 0, .17* .42 + 0.62 3.64 + 0.06 2.41 + 0. 06 1, ,09 + 0, .03 2, .23 + 0.10 
(6) (6) (6) (6) (6) (6) 
LPHZ - 2 1 .77 + 0.12 .53 + 0.37 4.01 + 0.26 2.52 + 0. 11 1, ,33 + 0. ,15 1. ,97 + 0.16 
(6) (5) (6) (6) (6) (6) 
HPLZ - 3 2 .36 + 0. ,22 5, ,77 + 0.45 4.97 + 0.22 2.87 + 0. 14 1. ,90 + 0. 07 1. ,51 + 0.03 
(6) (6) (6) (6) (6) (6) 
Control (HPHZ) — 4 2 .07 + 0. ,17 6. ,40 + 0.49 4.53 + 0.30 2.69 + 0. 15 1. 66 + 0. 15 1. 67 + 0.09 
(5) (6) (6) (6) (6) (6) 
T-test comparison 
between 
• LP treatments NS NS NS NS NS 
• HP treatments NS NS NS NS NS NS 
Significant dietary Small but No sig. Pr only Pr only Pr (Major Pr only 
effects insignificant Pr or Z effect) 
(P < 0.05) Pr effect effects Pr x Z 
only 
^Mean + SEM (No. of rats). 
^Pr = dietary protein; Z = dietary zinc; Pr x Z = interaction. 
Table 27. Plasma zinc, iron and proteins of rats after 14 days repletion with control (HPHZ) 
diet (Experiment IV: repletion) 
Depletion Zinc Iron Proteins (gm/dl) 
diets (•(j.g/ml) (j,g/ml) Total Albumin Globulin A/G ratio 
LPLZ - 1 1.78+0.07® 4.82 + 0.22 4.16+0.08 2.11+0.04 1.89+0.06 1.12+0.04 
(6) (5) (6) (6) (6) (6) 
LPHZ - 2 1.69+0.17 5.62+0.41 3.81+0.13 1.94+0.06 1 . 7 3  ± 0 . 0 8  1.13+0.04 
(6) (6) (6) (6) (6) (6) 
HPLZ - 3 2.15+0.13 4.20+0.38 4.61+0.17 2.17+0.04 2.25+0.13 0.98+0.06 
(6) (6) (6) (6) (6) (6) 
Control (HPHZ) - 4 2.16+0.12 4.29+0.42 4.35+0.06 2.17+0.03 2.01+0.06 1.09+0.04 
0% (6) (6) ((% (6) 
T-test comparison 
between 
• LP treatments 
• HP treatments 
NS 
NS 
NS 
NS 
NS 
NS 
A 
NS 
NS 
NS 
NS 
NS 
Significant dietary 
effects , 
(P < 0.05) 
Pr only Pr only Pr (Major 
effect) 
Z 
Pr (Major 
effect) 
Z 
Pr (Major 
effect) 
Z 
Small 
insig. 
Pr effect 
Mean + SEM (No. of rats) 
Pr = dietary protein; Z = dietary zinc. 
Table 28. Plasma zinc, iron and pro1:<iins of rats after 21 days repletion with control (HPHZ) 
diet (Experiment IV: repletion) 
Depletion Zinc Iron Proteins (am/dl) 
diets (Kg/ml) (pg/ml) Total Albumin Globulin A/G ratio 
LPLZ - 1 2.14 + 0.16* 4.07 + 0.25 4 .26 + 0.13 2.14 + 0.06 1.94 + 0.10 1.12 + 0.06 
(5) (4) (5) (5) (5) (5) 
LPHZ - 2 1.56 + 0.09 4.88 + 0.27 4 .22 + 0.23 2.15 4- 0.10 1.90 + 0.13 1.14 + 0.03 
(5) (4) (6) (6) (6) (6) 
HPLZ - 3 1.56 + 0.15 5.77 + 0.60 4 .65 + 0.15 2.13 + 0.05 2.33 + 0,14 0.93 4- 0.06 
(5) (4) (6) (6) (6) (6) 
Control (HPHZ) - 4 2.11 ^  0,17 4,30 + 0.42 4, .82 + 0.12 2.36 + 0.05 2.66 + 0.34 0.95 + 0.10 
(5) (5) (6) (6) (6) (6) 
T-test comparison 
between 
• LP treatments * NS NS NS NS NS 
# HP treatments * NS NS A NS NS 
Significant dietary Pr X Z Pr X Z Pr only No sig. Pr only Pr only 
effects Pr or Z 
(P < 0.05)° effects 
^Mean + SEM (No. of rats). 
^Pr = dietary protein; Z - dietary zinc; Pr x Z = interaction. 
Table 29. Liver iron and zinc of rats after 4 weeks on depletion diet (Experiment IV) 
Wet liver Iron Zinc 
Depletion 
diets 
weight 
(gm) 
7c liver 
moisture^ 
Dry liver 
(ttg/gm) 
Total liver 
(Mg) 
Dry liver 
(jig/gm) 
Total liver 
(w#) 
LPLZ - 1 1.2 4- 0.1^ 
(6) 
82.7 + 0.97 
(6) 
913.7 + 173.5 
(6) 
205.5 + 49.1 
(6) 
111.3 4- 21.5 
(6) 
25.0 4- 6.0 
(6) 
LPliZ - 2 1.6 + 0.2 
(6) 
87.0 + 1.6 
(6) 
793.4 + 128.6 
(6) 
155.7 + 29.1 
(6) 
138.7 4- 21.0 
(6) 
27.0 4- 4.9 
(6) 
HPLZ - 3 9.3 + 0.8 
(6) 
82.4 4- 0.65 
(6) 
131.1 + 7.0 
(6) 
213.5 4- 19.0 
(6) 
72.8 4- 1.9 
(6) 
119.9 4- 11.6 
(6) 
Control (HPHZ) - 4 10.2 1.2 
(5) 
83.9 + 1.06 
(6) 
102.4 4- 3.2 
(6) 
164.5 + 19.5 
(5) 
66.0 4- 3.5 
(5) 
108.8 4- 16.4 
(5) 
T-test comparison 
between 
• LP treatments 
• HP treatments 
NS 
NS 
c 
NS 
** 
NS 
NS 
NS 
NS 
NS 
NS 
Significant dietary 
effects J 
(P < 0.05) 
Pr only 
" 
Pr only No sig. 
effect of 
Pr or Z 
Pr only Pr only 
^Post water-perfusion. 
^Mean + SEM (No. of rats). 
""No data. 
= dietary protein; Z = dietary zinc. 
Table 30. Liver zinc and iron of: rata after 7 days repletion (HPHZ) diet (Experiment IV) 
Wet liver Zinc Iron 
Depletion 
diets 
weight 
(gm) 
7o liver 
moif! ture 
Dry liver 
(M,g/gm) 
Total liver 
(U'g) 
Dry liver 
(jxg/gm) 
Total liver 
(|ig) 
LPLZ - 1 3.1 + 0,25^ 
(6) 
79.4 + 0.58 
(6) 
87.0 + 3.0 
(6) 
55.4 f 5.4 
(6) 
265.0 + 16.0 
(6) 
166.0 + 12.9 
(6) 
LPHZ - 2 2,8 + 0.28 
(6) 
78.7 + 1.29 
(6) 
89.4 + 3.2 
(6) 
52.2 + 5.6 
(6) 
239.7 + 19.8 
(6) 
134.8 + 7.6 
(6) 
HPLZ - 3 8,6 + 0.45 
(6) 
78.!) + 0.82 
(6) 
77.8 + 3,5 
(6) 
140.7 + 10.3 
(6) 
215.1 + 8,6 
(6) 
388.7 + 25.8 
(6) 
Control (HPHZ) - 4 8.9 + 0.56 
(6) 
79.(3 + 0,80 
(6) 
71,1 -f 2.8 
(6) 
129.1 + 11.1 
(6) 
195.6 + 7.6 
(6) 
354.5 + 28.9 
(6) 
T-test comparison 
between 
# LP treatments 
# HP treatments 
NS 
NS 
_c NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
Significant dietary 
effects 
(P° < 0.05)® 
Pr only Pr only Pr only Pr only Pr only 
^Post-water perfusion, 
^Mean + SEM (No. of rats). 
^No data, 
^Probability. 
^Pr = dietary protein. 
Table 31, Liver zinc and iron of rats after 14 days repletion with control (HPHZ) diet 
(Experiment IV) 
Wet liver Zinc Iron 
Depletion 
diets 
weight 
(gm) 
% liver^ 
moisture 
Dry liver 
(ug/gm) 
Total liver (we) Dry liver (ug/gm) Total liver (w#) 
LPLZ - 1 6.31 + 0.62^ 
(6) 
82.4 + 1.3 
(6) 
83.3 + 6.9 
(6) 
91.1 + 13.1 
(6) 
246.3 + 22.4 
(6) 
267.4 + 33.7 
(6) 
LPHZ - 2 7.30 + 1.14 
(5) 
83.0 + 1.5 
(6) 
77.0 + 3.4 
(6) 
88.1 + 7.2 
(5) 
274.2 + 20.7 
(6) 
317.5 4- 45.5 
(5) 
liPLZ - 3 16.3 +1.69 
(6) 
84.8 + 0.7 
(6) 
77.0 -f 3.6 
(6) 
186.0 + 12.0 
(6) 
295.4 + 14.4 
(6) 
712.5 f 43.0 
(6) 
Control (HPHZ) - 4 15.7 + 1.49 
(6) 
84.1 + 0.6 
(6) 
77.4 + 4.3 
(6) 
192.8 + 22.7 
(6) 
241.8 + 14.9 
(6) 
593.8 + 52,8 
(6) 
T-test comparison 
between 
• LP treatments 
9 HP treatments 
NS 
NS 
_c NS 
NS 
NS 
NS 
NS 
* 
NS 
NS 
Significant dietary 
effects 
(P < 0.05)d 
Pr only No sig. 
dietary 
effect of 
Pr or Z 
Pr only Pr X Z Pr only 
^Post-water perfusion. 
^Mean + SEM (No. of rats). 
^No data. 
^Pr = dietary protein; Z = dietary zinc; Pr x Z = interaction. 
Table 32. Liver zinc and iron of rats after 21 days repletion with control (HPHZ) diet 
(Experiment IV) 
Wet liver Zinc Iron 
Depletion 
diets 
weight 
(gm) 
7, liver^ 
moisture 
Dry liver 
(n-g/gm) 
Total liver 
ClJ-g) 
Dry liver 
(iig/gm) 
Total liver 
(VJ'g) 
LPLZ - 1 8.14 + 0.49^ 
(5) 
82.4 + 0.7 
(5) 
77.1 + 1.12 
(5) 
109.4 + 4.2 
(5) 
193.1 + 12.9 
(5) 
273.9 + 20.1 
(5) 
LPHZ - 2 5,32 + 0.18 
(5) 
82.1 + 1.4 
(6) 
79.7 + 2.5 
(6) 
81.5 + 3.4 
(5) 
291.0 + 47.1 
(6) 
246.1 + 16.8 
(5) 
HPLZ - 3 11.9 + 1.68 
(5) 
81.0 + 2.1 
(6) 
63.7 + 2.2 
(6) 
153.0 4- 32.3 
(5) 
224.0 + 20.3 
(6) 
507.3 4- 100.8 
(5) 
Control (HPHZ) - 4 12.4 + 0.98 
(6) 
80.1 + 1.3 
(6) 
71.5 + 4.4 
(6) 
171.1 + 9.5 
(6) 
202.1 + 16.4 
(6) 
487.4 + 46.2 
(6) 
T-test comparison 
between 
• LP treatments 
# HP treatments 
** 
NS 
_c NS 
NS 
*A 
NS 
NS 
NS 
NS 
NS 
Significant dietary 
effects 
(P < 0.05)° 
Pr only Pr only Pr only No sig. 
effect of 
Pr or Z 
Pr only 
^Post water-perfusion. 
^Mean + SEM (No. of rats). 
^No data. 
^'pr = dietary protein; z = dietary zinc. 
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Figure 13. Graph suggesting a dilution of liver zinc towards normal levels in LP rats as fresh 
liver (tissue forms) during repletion. Rate of dietary zinc uptake into liver lags 
behind tissue biosynthesis during repletion (Tables 29-32) 
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plasma albumin concentrations while recovery of plasma globulin still 
lagged behind. 
The picture for liver iron and zinc at the end of depletion (Table 
29) was similar to what was seen in Experiment I (Table 12) and Experiment 
III (Table 17). Since these livers were perfused, the per cent liver 
moisture here does not represent the true composition of nonperfused 
liver (Tables 11, 12, Experiment I). Liver perfusion in this study 
was to check whether elimination of residual liver blood would change 
the general pattern of higher minerals (Fe^, Zn^, Na"*") concentrations 
in the PEN rats. 
After 3 weeks repletion (Table 32), liver weights, zinc and iron 
of PEM rats had not reached control levels yet. Main effects were due 
to dietary protein. Among th( PEM rats, those that had higher zinc 
status during PEM still had significantly (p ^  0.01) lower liver weights. 
They also had slightly higher concentrations of liver zinc and iron. 
The total liver zinc of the LPHZ rats was significantly lower than that 
of the LPLZ rats. 
The depletion data for sodium and protein in Table 33 have been 
discussed in connection with data from Experiments I and III. There 
were significantly higher liver sodium concentrations (ug/gm) in PEM 
rats and significantly lower liver protein in PEM rats. The difference 
between this and Experiment I (Table 11) and Experiment III (Table 18) 
is that no zinc effects occurred (Table 25). The only effects were 
from dietary protein. 
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After 3 weeks repletion (Table 36), liver protein concentrations 
(g/100 gm) were at control levels in all groups as indicated by the 
disappearance of significant dietary protein or zinc effects. Highest 
liver protein concentration (g/100 gm) was seen in the LPHZ livers. 
Total liver protein was significantly lower in the livers of the 
recovering PEN rats. This may be because of the lower liver weights 
of the recovering PEN rats. 
Altogether, there were not many significant dietary zinc effects 
in the liver analyses of Experiment IV. The effects still showed up 
in plasma analyses, mostly as secondary effects to those of dietary 
protein. 
There also seemed to be a general decrease in dietary effects on 
plasma and tissue minerals (Tables 28, 29, 32, and 36) with increasing 
repletion. 
Table 33. Liver sodium and protein of rats after 4 weeks on depletion diet (Experiment IV) 
Wet liver Sodium Protein 
Depletion 
diets 
weight 
(gm) 
% liver 
moisture 
Dry liver 
(Pg/gm) 
Total liver 
(M-g) 
Dry liver 
(gm/100 gm) 
Total liver 
(gm) 
LPLZ - 1 1.2 + 0.1^ 
(6) 
82.7 + 0.97 
(6) 
3410.8 + 644.4 
(6) 
773.5 + 184.6 
(6) 
62.1 + 0.76 
(6) 
0.13 + 0.01 
(6) 
LPHZ - 2 1.6 + 0.2 
(6) 
87.0 + 1.6 
(6) 
3208.4 + 500.6 
(6) 
632.8 + 116.5 
(6) 
60.5 + 2,21 
(5) 
0.11 + 0.01 
(5) 
HPLZ - 3 9.3 + 0.8 
(6) 
82.4 + 0.65 
(6) 
1675.2 + 106.5 
(6) 
2719.3 + 213.6 
(6) 
69,1 + 0.70 
(5) 
1.17 + 0.11 
(5) 
Control (HPHZ) - 4 10.2 + 1.2 
(5) 
83.9 + 1.06 
(6) 
1452.7 + 128.3 
(6) 
2352,3 + 313.9 
(5) 
68.1 + 2.28 
(6) 
1.13 + 0.16 
(5) 
T-test comparison 
between 
• LP treatments 
• HP treatments 
NS 
NS 
c 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
Significant dietary 
effects 
(P^ < 0.05)2 
Pr only Pr only Pr only Pr only Pr only 
^Post-water perfusion. 
^Mean + SEM (No. of rats). 
^ No data. 
^ Probability.. 
^Pr = dietary protein. 
Table 34. Liver sodium and protein of rats after 7 days repletion with control (HPHZ) diet 
(Experiment IV) 
Wet liver 
% liver^ 
Sodium Protein 
Depletion weight Dry liver Total liver Dry liver Total liver 
diets (gm) moisture (tig/gm) (^) (gm/100 gm) (gm) 
LPLZ - 1 3.1 + 0.25^ 79.4 + 0.58 2615.7+ 177.0 1645.6 + 149. 7 62.9 + 1.72 0.40 + 0.04 
(6) (6) (6) (6) (6) (6) 
LPllZ - 2 2.8 + 0.28 78.7 + 1.29 2784.8+ 180.5 1587.2 + 126. 4 63.9 + 2.07 0.40 + 0.03 
(6) (6) (6) (6) (5) ( 5 )  
HPLZ - 3 8.6 + 0.45 78.9 + 0.82 2049.6 + 104.8 3685.6 + 220. 0 62.6 + 1.54 1.14 + 0.05 
(6) (6) (6) (6) (5) (5) 
Control (HPHZ) — 4 8.9 + 0.56 79.6 + 0.80 2168.7+ 30.6 3929.6 + 281. 3 64.5 + 1.76 1.17 + 0.09 
(6) (6) (6) (6) (6) (6) 
T-test comparison 
between 
0 LP treatments NS NS NS NS NS 
• HP treatments NS — NS NS NS NS 
Significant dietary Pr only — Pr only Pr only No dietary Pr only 
effects effect of 
(pd < 0.05)® Pr or Z 
^Post-water perfusion. 
^Mean + SEM (No. of rats). 
^No data, 
^Probability, 
^Pr = dietary protein; Z = dietary zinc. 
Table 35, Liver sodium and protein o£ rats after 14 days repletion with control (HPHZ) diet 
(Experiment IV) 
Wet liver Sodium Protein 
Depletion 
diets 
weight 
(gm) 
% liver^ 
moisture 
Dry liver 
(txg/gm) 
Total liver 
(M.g) 
Dry liver 
(gm/100 gm) 
Total liver 
(gm) 
LPLZ - 1 6.31 + 0.62^ 
(6) 
82.4 4- 1.3 
(6) 
2542.0 + 175.4 
(6) 
2789,0+ 374, 
(6) 
5 62.2 + 1.64 
(6) 
0.71 + 0.06 
(6) 
LPHZ - 2 7,30 + 1.14 
(5) 
83.0 + 1.5 
(6) 
2242.3 + 110.4 
(6) 
2647.5 + 346, 
(5) 
1 65.6 + 0.85 
(6) 
0.74 + 0.06 
(5) 
HPLZ - 3 16,3 + 1.69 
(6) 
84.8 + 0.7 
(6) 
2124.3+ 135.8 
(6) 
5222.1 + 595. 
(6) 
8 63.9 + 1.78 
(6) 
1.55 + 0.11 
(6) 
Control (HPHZ) - 4 15.7 + 1.49 
(6) 
84.1 + 0.6 
(6) 
2316.5 + 169.9 
(6) 
5652.2 f494. 
(6) 
8 62.4 + 2,41 
(6) 
1.53 + 0.11 
(6) 
T-test comparison 
between 
* LP treatments 
• HP treatments 
NS 
NS 
__c 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
Significant dietary 
effects 
(P(l < 0.05)2 
Pr only No sig, 
effect of 
Pr or Z 
Pr only No sig, 
effect of 
Pr or Z 
Pr only 
^Post water-perfusion. 
^Mean + SEM (No. of rats). 
^No data, 
^Probability, 
^Pr = dietary protein; Z = dietary zinc. 
Table 36. Liver fiodium and protein of rats after 21 days repletion with control (HPHZ) diet 
(Experiment IV) 
Wet liver Sodium Protein 
Depletion 
diets 
weight 
(gui) 
% liver^ 
moisture 
Dry liver 
(Pg/gm) 
Total liver 
(Mg) 
Dry liver 
(gm/100 gm) 
Total liver 
(gm) 
LPLZ - 1 8.14 + 0.49^ 
(5) 
82.4 + 0.7 
(5) 
1990.2 + 106 
(5) 
.7 2817.3 + 147, 
(5) 
,8 61.9 + 1.58 
(5) 
0.88 + 0.05 
(5) 
LPHZ - 2 5 .32 + 0.18 
(5) 
82.1 + 1.4 
(6) 
2144.2 + 108 
(6) 
.2 2089.8+ 50.8 
(5) 
69.1 + 1.89 
(6) 
0.68 + 0.04 
(5) 
HPLZ - 3 11 .9 +1.68 
(5) 
81.0 + 2.1 
(6) 
1968.1 + 183 
(6) 
.4 5138.6 + 1205. 
(5) 
2 64.5 + 2.33 
(6) 
1.49 + 0.25 
(5) 
Control (HPHZ) - 4 12 .4 + 0.98 
(6) 
80.1 +1.3 
(6) 
1954,6 + 208 
(6) 
.0 4675.7 + 478. 
(6) 
6 64.3 + 3.1 
(6) 
1.54 + 0.06 
(6) 
T-test comparison 
between 
e LP treatments 
o HP treatments NS 
_c NS 
NS 
AA 
NS 
* 
NS 
* 
NS 
Significant dietary 
effects 
(P < 0.05)* 
Pr only 
" 
No sig. 
effect of 
Pr or Z 
Pr only No sig. 
effect of 
Pr or Z 
Pr only 
^Post water-perfusion. 
^Mean + SEM (No. of rats). 
^No data. 
"^Pr = dietaiy protein; Z = dietary zinc. 
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Figure 14. Increasing tocal liver zinc with repletion and growth. 
PEM rats previously on LPH2 diet lag behind PEM rats pre­
viously on LPLZ diet (Tables 33-36) 
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Figure 15. Increasing total liver protein with repletion and growth 
in all groups. Rats previously on LPHZ diet were behind LPLZ 
rats after 3 weeks (Tables 33-36) 
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Figure 16. Rats previously on LPHZ diets show better rate of liver protein biosynthesis than 
LPLZ rats after 3 weeks (Tables 33-36). Figure 15 suggests that total liver 
weight was still lower at this time in LPHZ group than LPLZ group 
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DISCUSSION 
The Rat Model for PEM 
The results of depleting rats fed the diets (Table 1) used in 
this study indicate a successful induction of clinical PEM in our Wistar 
rats. Loss of appetite, loss of body weight, edema, hair disorders, 
dermatosis, lethargy, severe hypoalbuminemia, low plasma A/G ratios (Tables 
5 and 22) are documented symptoms of kwashiorkor (5, 83, 84, 85). 
A striking feature of this study is the rapidity with which PEM 
developed. Edozien, using 0.5% lactalbumin found that rats took 3.5 months 
to develop kwashiorkor (85). Feeding egg albumin - a higher quality pro­
tein - at 0.4%, we expected kwashiorkor later than the 4 weeks within which 
it occurred. The biological values of egg ablumin and lactalbumin are 
97% and 84%, respectively (86). The rapid development of edema may be due 
to our use of younger, newly-weaned (45 gm average weight) rats. Edozien 
used older (100-130 gm) rats. This might suggest a more rapid development 
of PEH in younger human infauLs. Next to edema, some consider fatty 
liver the second major difference between kwashiorkor and marasmus (87). 
It does not occur in all cases of kwashiorkor (88) and it did not occur 
in our rats. Surcrose-containing protein-deficient diets usually induce 
kwashiorkor with fatty liver (83, 85). Hypoalbuminemia and other kwashior­
kor symptoms are produced along with it. Fructose, from the sucrose, is 
considered mainly responsible for the fatty livers (89). Liver has a 
glucûkinase but no hexokinase for production of fructose-6-phosphate. 
Therefore, a direct link with the glycolytic pathway is missing. Instead, 
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fructose undergoes a series of reactions in the liver that stimulate 
hepatic triglyceride synthesis: 
D-GIyceraIdehyde atp adp 
D - Fructose 
NADH4-] yceraldehyde 
-3- Pfc 
NA] 'ADH, 
'AD 
Glyc er ophos pha te Phosohatidate. 
• ZCoh-S'A. 2FA-COA 
i 
[ Trigl^erldes ^ 
There is reduced protein biosynthesis in the liver in kwashiorkor 
(24, 90, 91). The triglyceride cannot be incorporated into chylomicrons 
and so is deposited in the liver. It also mighi. be possible that an infant 
developing kwashiorkor on a cassava-rich diet can develop fatty liver. 
It should not be because of stimulation of hepatic triglyceride synthesis 
but because of a direct breakdown in the mechanism for making chylomicrons 
(i.e., lipoproteins) (92). By Waterlow's classification (13), subjects 
weighing less than 60% of the standard weight-for-age and showing edema, 
have marasmic-kwashiorkor. Taking our control rat weights as "standard 
weight-for-age," both groups of our PEM rats (LPLZ and LPHZ) may more 
correctly be described (Table 2) as marasmic-kwashiorkor models. Also, 
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the fluctuating nature of the edema in some rats of this study will 
perhaps identify more easily with the marasmic-kwashiorkor syndrome. 
The occurrence of serious eye disorders in 30% of the LPLZ and 
only 10% of the LPHZ groups, suggest the possibility that xerophthalmia 
in kwashiorkor occurs where serious zinc deficiency is also present. This 
is speculative because Vitamin A status was not determined in these 
experiments. 
Liver Pathology and Alteration 
The following differences were noted between livers of the PEM and 
nonPEM rats: 
1) Significantly elevated liver moisture among PEM rats 
(Table 8). 
2) Significantly elevated liver concentrations of Cu"^, 
Zn"^, Fe"^, Na"^ (Tables 8, 9 and 12) in PEM. 
3) Significantly depressed liver protein concencracions in 
PEM (Tables 8 and 25). 
4) In comparison with the brain or kidney, the liver is more 
severely diminished in weight in PEM (Tables 4, 13, and 26), 
Diminution of liver weight 
Among the organs examined, the spleen seemed the most retarded in 
growth, followed by the liver, the kidney and the brain in that order 
(Tables 4 and 15). The lower effect of protein depletion on brain weight 
suggests that most of its growth occurred in the pre-weaning period before 
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the rats entered the experiment. Liver and spleen were, however, growing 
very actively at the beginning of the experiment and were very dependent on 
dietary protein. Literature reports rapid brain growth (1-2 mg wt. 
increase/min.) at birth (16). 
An interesting observation is the liver/body weight ratio (Table 4) 
which is about 0.03-0.04 regardless of dietary protein or zinc treatment. 
This suggests a very close positive correlation between body weight and 
liver weight. It might be possible to derive a good prediction equation 
liqking body weight to wet liver weight. 
Elevated liver minerals 
McLaren (93) points out that as a rule, essential elements such as 
zinc, iron, copper, sodium, etc. tend to accumulate in liver during 
physiological disorders. Nonessential elements tend to accumulate in the 
kidney and bone. Compared with controls, the PEM rats (75) showed about 
20% more liver moisture for 100 gm liver. They showed 700-800% more iron/ 
grp. dry liver (Table 26) ; 170-210% ™ore zinc per gm dry liver atid 220-223% 
more sodium/gm dry liver (Table 33). Quantitatively, the sodium increases 
(expressed in pg). The ratios of Zn:Fe:Na per gm dry liver in controls 
(Tables 13 and 14) were 5:7:88 as compared with 2:18:80 in PEM rats. 
Absolute amounts of these elements in PEM rat livers were higher as shown. 
Increases in liver zinc and iom appear to be due to unavailability 
of adequate protein to bind and transport them out. About 66% of all zinc 
is transported bound to ablumin, 30% to alpha2-macroglobulins, some to 
transferrin, nucleoproteins, metallothionen, cystine and histridine. Iron 
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is transported by transferrin. Its release from the liver also requires 
the enzyme xanthine oxidase (25) - a protein. Because of depressed 
hepatic protein biosynthesis in PEM (91, 92, 94), these elements cannot be 
moved out of the liver. Overal rates of protein turn over in children 
decrease by about 40% in PEM (90). Our correlation data (Table 9B), show 
strong negative correlations (p _< 0.0001) between liver protein concentra­
tion (gm/100 gm wet liver) and liver zinc, copper and iron concentrations 
(}ig/gm). The same is true for sodium. This could mean that increased pro­
tein biosynthesis in the liver leads to increased removal of Zn, Fe, Cu and 
Na"*" from the liver. A factor that may be more responsible for the in­
creased sodium concentration is increased plasma aldosterone concentration 
in kwashiorkor (16, 93, 95). While aldosterone secretion remains un­
changed, its catabolism is lowered in kwashiorkor because of disorders of 
the liver. This will increase k"*" excretion and Na"*" retention. 
Elevated liver moisture 
Retention of sodium in liver, because of the aldosterone effect, also 
will cause an influx of water becuase of osmotic pressure elevation by 
sodium. Breakdown of cytosolic protein and removal of the amino acids in 
PEM will reduce cytosolic colloid osmotic pressure. This is apparently 
insufficient to reverse water influx due to the increased osmotic pressure 
caused by sodium. The increased liver moisture possibly contributes to the 
hepatomegaly (84) in kwashiorkor. The sodium retention due to aldosterone 
perhaps contributes significantly to edema. A combination of hypoalbumin-
emia (Tables 6, 11 and 21) and sodium retention in the extracellular fluids 
may completely account for the edema (96). 
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Reduced liver protein concentration 
PEM rats had significantly reduced liver protein concentrations 
(Tables 8 and 25). There are several literature reports of serious 
decrease in hepatic protein biosynthesis in PEM (91, 92, 94J. Plasma 
albumin synthesis occurs in the liver. A reduction in hepatic protein 
biosynthesis, therefore, leads to hypoalbumineraia. With an adequate 
protein diet, the liver synthesizes and exports about 30% of its own 
protein mass daily in rats (24, 97). In marasmus, muscle breakdown 
provides amino acids to liver for synthesizing export proteins (plasma 
proteins, etc). In kwashiorkor, an adequate supply of amino acids to 
liver via muscle breakdown is prevented because of a lowered plasma 
cortisol/insulin ratio. In kwashiorkor, the liver breaks down its own 
proteins — mainly cytosolic proteins like enzymes (24, 90) — to obtain 
amino acids to continue synthetizing export proteins. Our data (Table 8) 
showing severe liver protein decreases on a wet-weight basis, as com­
pared with dry-weight basis, reflects both the lowered cytosolic protein 
content as well as elevated moisture in PEM livers. In a direct measure­
ment, Atshushi et al. (91) demonstrated about 38% decrease in rate of pro­
tein synthesis in rat liver after 10 days of dietary protein depletion. 
Mineral Interrelationships 
Zinc and iron 
In all three experiments (I, III and IV) in which tissue analyses 
were done, low dietary zinc caused significantly increased tissue iron 
concentrations. This increase was seen for liver (Tables 9, 13, and 
106 
and 23); for muscle (Tables 10 and 12); for brain (Table 15). Settle-
mire and Matrone (98) proposed that decrease in tissue iron at high 
dietary zinc results from inhibition of iron incorporation into ferritin, 
its increased release or both. Kang et al. (99) showed, as we have 
done also in this study, that this effect of dietary zinc on iron does 
not occur only at the toxic zinc levels reported by Settlemire and 
Matrone but also at subtoxic or normal dietary amounts of zinc. Be­
cause both zinc and iron bind to transferrin (100), high dietary zinc 
should reduce iron intake to liver because of competition for binding 
with transferrin at the serosal side of the intestinal mucosa. 
Zinc and sodium 
A relationship similar to that of zinc and iron was noted between 
zinc and sodium in all three tissues. Low dietary zinc produced high 
sodium concentrations and high dietary zinc caused low tissue sodium 
concentrations. This is seen in muscle (in Table 12), liver (Tables 14 
and 25); and brain (Table 16). Possibly, a similar relationship will 
exist between iron and sodium. Apart from one study (82) reporting an 
effect of dietary zinc on leucocyte sodium transport, no literature has 
been seen on this zinc-sodium relationship. We have confirmed that in 
addition, to the leucocyte, this relationship exists in other tissues, 
i.e.. liver, muscle and brain. This occurs not only in PEM but also in 
protein-adequate rats as well (Tables 14 and 16). Patrick et al. 
showed that sodium transport out of the leucocyte was stimulated by 
increased dietary zinc. The same mechanism may be responsible for the 
results we saw in liver, brain and muscle — i.e., effects of zinc on the 
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sodium pump. Given the stimulatory effect of zinc on EFA and triglyceride 
synthesis (51, àZ, 101), it is possible that low zinc causes disintegration 
of cell membranes and inactivation of the sodium pump in the process. 
Sodium will consequently accumulate within cells. Elevation of dietary 
zinc may correct the disorder and enable the sodium pump to function 
properly. Some researchers (96, 102, 103) suspect a breakdown of the 
sodium pump as contributing to Na"^ accumulation in ECF in kwashiorkor — 
leading to edema. The detailed role of aldosterone here needs, however, 
to be clarified. 
Zinc and copper 
No significant relationship was seen between dietary zinc and tissue 
copper (Tables 5, 6, 8, and 16). Kang et al. (99) made the same 
observation about hepatic copper. 
Possible Dietary Zinc Toxicity in PEM 
Comparisons here are mainly betr^een the two groups of rats on low 
dietary protein. One group was fed deficient dietary zinc (LPLZ) and 
the other on moderately high dietary zinc (LPHZ). Both developed 
PEM but had some differences. 
At the beginning of protein-depletion, decreased food intake 
first occurred in (Table 1) the LPHZ group. This continued until 
the 3rd week when the cumulative food intake of the LPLZ rats fell 
behind the LPHZ rats. The LPLZ rats may have become depleted of zinc 
by the 3rd week and suffered further loss of appetite. These numerical 
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differences, though not quite significant statistically, were observed 
again in subsequent studies. 
Reflecting the food intake data, the LPHZ rats lost weight faster 
(Table 2) in the first three weeks than the LPLZ rats. After 2 days of 
depletion, the LPHZ rats weighed significantly (p _< 0.05) less than the 
LPLZ rats. Between the 3rd week and the time of mortality, LPLZ rats lost 
enough weight to catch up with the LPHZ rats. Urine creatinine (Table 3) 
was also much lower among LPHZ rats, suggesting less musculature. 
Significantly lower (p _< 0.01) plasma protein concentration occurred 
in the LPhZ rats (Table 6) in Experiment I. Similar trends occurred in 
Experiment III (Table 11) and Experiment IV (Table 21). 
LPHZ rats had lower liver protein concentrations (gm/100 gm) than the 
LPLZ rats (Table 8). Though not statistically different, the same trend 
showed up again in Experiment IV (Table 30). From the end of depletion 
(Table 21) through the period of repletion (Tables 26, 27, and 28) in 
Experiment IV, plasma iron and other parameters were measured each week. 
For most of that time, the LPHZ rats had higher plasma iron levels than 
either LPLZ or the control (HPHZ). For PEM animals, high plasma iron 
levels may be more deleterious. Much of their iron, not being bound to 
transferrin, is free and promotes bacterial multiplication and, therefore, 
infection (16). Because the LPHZ rats already had significantly lower 
plasma globulin concentrations (Table 6), their immune response to infec­
tion should be very weak; antibody concentrations (immunoglobulins) should 
be low. Earlier mortality should occur in this group, in comparison with 
the LPLZ group, during PEM. The failure for a significant difference to 
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occur between LPLZ and LPHZ plasma iron levels (Table 21) after depletion, 
may be due to the small number of measurements (n - 4) in the LPLZ group. 
The standard error of the mean in this group was high because the number 
was small. A closer examination of plasma iron levels coupled with 
bacterial counts in the LPLZ and LPHZ groups would be useful in future 
studies. 
Mortalities occurred significantly (p £ 0.01) earlier by 2 weeks in 
the LPHZ rats in Experiment I (Table 10). Considering a 3-year life-span 
for the rat and a 50-year life expectancy for a developing country with 
much PEN, the mortality results will suggest 8-month earlier mortality (on 
the average) for a kwashiorkor child if he should ingest even moderately 
high dietary zinc than if he did not. In Experiment II, deaths again 
appeared to start earlier among the LPHZ rats (Table 18 and Figure 11) but 
differences between the mean lengths of time before mortality were not 
significant. 
With both groups of PEM rats eating the same high-protein diet of the 
controls for repletion, the rats previously on LPLZ diet recovered faster 
than those originally on LPHZ diet. Possibly the disorders caused by 
ingesting moderately high zinc in PEM made recovery slower for the LPHZ 
group. After 3 weeks of repletion, the previous LPHZ group compared with 
their previous LPLZ counterparts as follows: 
1) Significantly lower (p _< 0.01) total liver zinc and lower 
total liver iron (Table 24). 
2) Significantly (p £ 0.01) lower total liver sodium (Table 26) 
and significantly (p _< 0.01) lower total liver protein. 
110 
3) Twenty per cent lower body weights than (Table 20) after 3 
weeks repletion. This weight-for-age measurement is one of the criteria 
for classifying PEM in children (13). Also, weight-for-height is 
frequently used (62). A child with kwashiorkor is considered ready for 
clinical discharge when he attains normal weight-for-height. 
The diets used for the repletion phase (i.e., control diets during 
depletion) satisfied conditions needed for rapid "catch-up" growth in 
kwashiorkor patients: (A) at least 10% of the total dietary energy should 
be from dietary protein (63, 66); protein provided 19% of the total 
energy of the HPHZ repletion diet (i.e., P:E ratio = 0.19); and (B) the 
diet was more than sufficient in vitamins, minerals and fats. 
The consistently lower plasma protein concentrations of the LPHZ 
group, their lower liver protein and iron concentrations, the slight but 
consistently lower body weight after depletion, their earlier onset of 
mortality during depletion, higher plasma iron and slower recovery 
during repletion, all suggest a possible dietary zinc toxicity. 
Cousins (104) explained that high dietary zinc induces métallothionein 
synthesis in the intestinal mucosa as well as in hepatocytes. This 
may be one important difference between our two PEM groups. Induction 
of thionein protein first involves nucleic acid biosynthesis. In addi­
tion to this being an energy requiring process, purine synthesis re­
quires extensive amino acid usage; glutamate, glycine, aspartate and 
glutamine are all required. This means a diversion of energy and amino 
acids into nucleic acids and métallothionein in the LPHZ rats. This 
could possibly contribute to the significantly lower plasma protein 
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Figure 17. Toxicity of 30 ppm dietaiy zinc in PEM rats would suggest drastically reduced 
therapeutic margin for dietary zinc in PEM. Control rats are known to show no 
toxic effects on up to 7000 ppm dietary zinc. 
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concentrations of the LPHZ rats, compared with the LPLZ rats. This might 
also contribute to a lower body weight and lower overall musculature (as 
measured by urine creatinine) in the LPHZ rats. It may be worth comparing 
intestinal and hepatic nucleic acid concentrations in the LPLZ and LPHZ 
groups in the future. 
In relationship to this possible dietary zinc toxicity to the PEN rat 
at a moderate level of 30 ppm. Smith and Larson (103) noted zinc toxicity 
in young healthy rats at 7000 ppm diet. At 10,000 ppm, 75% of their rats 
died in 3-5 weeks. The young rats fed adequate dietary protein also showed 
anemia and subnormal growth. We did not check for anemia, but subnormal 
growth (lower body weight; lower overall musculature) were present in the 
LPHZ rats. 
Zinc toxicity at 30 ppm dietary zinc indicates that there is a drasti­
cally reduced tolerance to excess dietary zinc in the rat with kwashioror. 
In toxicological terms, there is a drastically reduced therapeutic range 
(105) for dietary zinc in the PEM rat. The toxic effect curve (Figure 17) 
is shifted far to the left with a decrease in the therapeutic margin. 
In health, the rat requires 12 ppm dietary zinc. When consuming a soy 
protein based diet, this increases to 18 ppm (106) because of unavail­
ability of zinc bound by phytate. The 30 ppm in our diet thus represents 
a very moderate excess above the requirement. 
Since iron uptake into tissues is hindered by high dietary zinc 
(98), hemopoiesis should decrease leading to anemia as reported by Smith 
and Larson (103). 
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Some Specific Contributions of Dietary Protein 
and Zinc to Kwashiorkor 
Loss of appetite and growth failure 
For the first 2 weeks of the study, the significantly lower food 
intake and body weights of the rats on low protein diets were due solely 
to effects of dietary protein. This can be seen in Tables 1 and 2. 
Thus, the kwashiorkor syndrome is initiated specifically by dietary 
protein deficiency. Dietary zinc effects developed after 2 weeks. 
By this time, if the diet was zinc-deficient, tissue zinc was depleted, 
causing further loss of appetite and body weight. When dietary zinc 
was low, the zinc deficiency effects on body weight were secondary to 
the protein effects. 
The same was true for the decreased body lengths (Table 3) and low 
organ weights (Tables 4, 15, and 23). Whereas adequate dietary zinc (12 
ppm) might not produce these adverse effects of 30 ppm zinc, all excess 
levels may be toxic to some extent. 
Edema and liver moisture 
There is no significant dietary zinc contribution to either edema 
(Table 18) or moisture increases in the liver. Dietary protein deficiency 
(as seen in Table 13) is the sole cause of these symptoms. In kwashiorkor, 
hypoalbuminemia and sodium retention in the extracellular fluid (ECF) 
have been reported jointly responsible for edema (82, 96). Our study 
shows that both hypoalbuminemia (Tables 6, 11, and 21) and tissue 
sodium levels (Tables 12, 14, and 25) are dependent on dietary protein 
concentrations where water accumulation occurs. 
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Significant dietary zinc effects on tissue sodium occur in the 
brain (Table 16), but no moisture accumulation occurs there (Table 15). 
Body edema and high moisture in PEM rat livers are solely due to the 
effects of dietary protein deficiency. 
Brain disorders 
Brain disorders occur in kwashiorkor as well as in dietary zinc 
deficiency (1, 5, 95, 107, 108, 109). Irreversible brain damage may occur 
if kwashiorkor occurs before the usual weaning time (16, 108). Apart from 
this, repair can slowly occur. Bartel et al. (110) report that even 12 
years after clinical kwashiorkor, development of the brain may not have 
been complete. There might still be a higher level of slow brain-wave 
activity than normal. It appears from a 15-year follow-up study that 
former kwashiorkor patients have close to normal mental performance at 
that time (111). 
Our study suggests more effect of dietary zinc on the brain than on 
cthertissues examined. Brain iron levels (Table 15) were directly depen­
dent on dietary zinc. Brain zinc (tig/gm wet tissue) and sodium (yg/gm^ 
dry tissue concentrations were solely influenced by dietary zinc 
levels. The data in Table 16 suggest that a zinc-deficiency state, 
whether in PEN or not, will increase sodium (mg/gm dry weight) concentra­
tion in the brain. Physiologically, if sodium should accumulate intra-
neurally and cannot be actively pumped out(31a, 82) nerve cells will 
be depolarized and not carry normal impulses. A refractory state re­
sults. This might slow down generation of nerve impulses and contribute 
to the physiological disorders of kwashiorkor and zinc deficiency. 
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Alkaline phosphatase 
Plasma alkaline phosphatase activities (Figure 4) followed the pat­
tern reported in literature (112, 113). The highest activities occur 
in young animals with rapidly growing bones. With age, plasma activities 
of this enzyme fall. Neither dietary protein nor the moderate dietary 
zinc deficiency significantly affected plasma alkaline phosphatase 
activities (Tables 5, 6 and 7). This casts doubt on the sensitivity 
of plasma alkaline phosphatase as a tool for measuring zinc status (28). 
Mortality rates 
Mortality rates (Tables 10 and 18) were affected by dietary protein, 
zinc and protein-zinc interactions. The largest effects were from pro­
tein deficiency. 
In summary, kwashiorkor is a protein-deficiency syndrome; only 
protein deficiency initiates it. If accompanied by moderate zinc de­
ficiency (as seems to be a usual human circumstance), mortality would 
be due mainly to the dietary protein deficiency. Dietary zinc can, 
however, aggravate protein deficiency disease. Moderate zinc excesses 
can cause significant decreases in plasma proteins (especially globulins). 
This excess may slow down overall protein biosynthesis, elevate plasma 
iron and promote earlier mortality. Zinc deficiency can significantly 
increase brain sodium levels with possible adverse effects on the central 
nervous system. Zinc deficiency also contributes to further decrease in 
appetite and loss of body weight. Dietary zinc levels near the normal 
requirement may be safer than even moderately excessive ones. 
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SUMMARY 
Four dietary treatments of rats with different levels of protein 
and zinc were used: 
(a) LPLZ — low dietary protein (0.4%) and moderately low zinc 
(6 ppm) . 
(b) LPHZ — low dietary protein and moderately high (30 ppm) 
zinc. 
(c) HPLZ — high dietary protein (20%) and moderately low zinc. 
(d) HPHZ — 20% protein and 30 ppm zinc for controls. 
Loss of appetite, body weight, development of edema, lethargy, 
hair disorders, skin dermatosis, severe hypoalbuminemia occurred in 
the rats fed the low-protein diets. These symptoms of kwashiorkor 
occurred within 4 weeks. 
The loss of appetite and body weight were initiated by protein 
deficiency only. When moderate dietary zinc deficiency was present 
further loss of appetite and body weight occurred a bit later. 
Decreases in total plasma protein levels were contributed to 
significantly by dietary protein and zinc deficiencies, as well as 
their interactions. The primary cause was dietary protein deficiency. 
Albumin levels were affected only by dietary protein while globulin 
levels were affected by both dietary protein and zinc. 
Dietary zinc deficiency made no significant contribution to edema 
or elevated liver moisture observed in rats with PEM. Only dietary 
protein effects were responsible for these conditions. No moisture 
increase was seen in the brain with any dietary treatments. Muscle had 
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small increases in moisture content. The livers had elevated zinc, 
iron, sodium and copper concentrations. The Na"*" elevation may have 
substantially contributed to elevated moisture of tissues in the rats 
with PEM. 
Main effects of dietary zinc were primarily in the brain. While 
Na"'" elevation in the liver was a main effect of dietary protein deficiency, 
increased sodium in the brain was due to dietary zinc deficiency. Even 
more strongly than with sodium, brain iron changes were controlled en­
tirely by effects of zinc deficiency. Plasma iron concentrations of 
both PEM and nonPEM rats were also controlled by effects of dietary 
zinc. It is proposed that intraneural accumulation of sodium, ac-
COTipanying suppression of sodium-pump activity should be carefully 
checked in kwashiorkor as well as in zinc-deficiency. 
A zinc-sodium relationship, similar to the well-documented zinc-
iron relationship was noted in all the three tissues studied, liver, 
muscle, brain. Low dietary zinc caused elevated tissue sodium whereas 
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work of Patrick et al. (82) who reported this relationship in leuco­
cytes of children with PEM. They attributed this effect to a decrease 
in sodium-pump activity in zinc deficiency and increase with adequate 
dietary zinc. We saw the relationship both in the PEM and nonPEM 
condition. 
The results in this study also suggest increased toxicity of excess 
dietary zinc in animals with PEM. While dietary zinc toxicities have 
been reported in normal animals with 7000 ppm, there seem to be 
toxicity symptoms in the PEM rat at 30 ppm dietary zinc. This is only 
a very small excess above the 12 ppm dietary zinc requirements for the 
rat. Marginal toxicity symptoms of 30 ppm zinc were seen in LPHZ rats 
as: 
1) significantly lowered plasma protein concentrations; 
2) elevated plasma iron concentrations. Lowered liver protein 
and body weights; 
3) significantly earlier mortality in one study and (not 
significant but) earlier mortality in another study; 
4) slower rate of recovery during repletion. This was shown by 
lower body weight at end of repletion and significantly 
lower liver zinc, sodium and protein. 
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